Not financial advice. All signals are advisory only. No position sizing recommendation here constitutes an order or instruction to trade. Verify all data independently before making any investment decision.
Top 3 to Buy
No signals of this type today.
Top 3 to Sell
AGCO — conviction 0.95
Why: The investment fails primarily due to a combination of deteriorating fundamentals and significant regulatory/macro headwinds. The Piotroski F-score of 1 indicates severe fundamental deterioration, and the current price of 107.52 sits above the Graham Number of 97.3789, resulting in a negligible Margin of Safety of 2.78%. The News digest provided a clear ‘Ugly’ signal regarding an FTC and USDA inquiry into farm equipment market practices and falling crop prices, which, combined with a ‘risk-off’ macro regime (GPR percentile 89.82), creates a high-risk profile that the current valuation does not adequately buffer. All committee members reached a ‘Fail’ consensus based on these factors.
Key Risks: Regulatory probe by FTC and USDA into farm equipment market practices; Falling crop prices impacting demand for farm equipment; Piotroski F-score of 1 indicating deteriorating financial health; Insufficient Margin of Safety (2.78%) in a risk-off macro environment
AGNC — conviction 0.95
Why: The investment is rejected primarily due to a critical failure in fundamental health. The Piotroski F-score of 1 (the lowest possible score) indicates severe financial distress or deteriorating fundamentals, which the committee consensus identifies as a ‘value trap.’ While the Graham Number of 20.014 suggests a 33.05% margin of safety against the current price of 8.61, this discount is deemed to be a reflection of high risk rather than an undervalued opportunity. The ‘risk_off’ macro regime (GPR percentile 89.82) and the news digest—which showed a ‘Bad’ signal via a lowered price target from Piper Sandler—further reinforce the case that the company faces significant headwinds. The news digest specifically highlighted the lowering of the price target to $10, which signaled a cooling of expectations and a deteriorating outlook.
Key Risks: Critical fundamental weakness (Piotroski F-score of 1); Risk-off macro environment with high GPR percentile (89.82); Potential value trap where low price reflects deteriorating fundamentals; Lowered price target by Piper Sandler indicating cooling sentiment
AGRO — conviction 0.95
Why: The investment fails primarily due to severe fundamental deterioration and a lack of margin of safety. The Piotroski F-score of 1 is a critical red flag, indicating extreme weakness in profitability, liquidity, or operating efficiency. This is compounded by a Value Score of only 1.33 and a current price of 10.54, which sits above the Graham Number of 10.2872, providing no buffer against downside risk. The News Digest showed a ‘Bad’ signal with a 22% fall in Wilmar earnings, suggesting operational instability. While the ‘risk_off’ macro environment and ‘Consumer Defensive’ classification might typically offer some protection, the internal evidence of fundamental decay and the lack of a valuation cushion make the asset unsuitable.
Key Risks: Piotroski F-score of 1 indicates severe financial distress; Price of 10.54 exceeds the Graham Number of 10.2872, eliminating margin of safety; Significant 22% fall in Wilmar earnings as reported in news digest; Risk-off macro environment (GPR percentile 89.82) penalizes low-quality assets
Run Summary
- Started: 2026-10-14T10:30:01Z
- Finished: 2026-10-14T12:32:04Z
- Covered: 118 tickers
- Deferred (deadline): 82 tickers — CGABL, CHCI, CHMI, CHTRP, CIM, CJMB, CLAR, CLB, CLH, CMCO, CMTG, CNMD, CNSY, CNX, CNXC, COLM, CON, COPR, COSO, CPA, CPK, CPRT, CRBG, CRH, CRML, CRMT, CRUS, CRWD, CSPI, CSTE, CTO, CTRI, CTSH, CUBI, CUVL, CVCO, CVU, CWK, CXAI, CXT, CZFS, CZR, DAAQ, DAL, DAN, DASH, DCOM, DEI, DFDV, DIBS, DJCO, DMC, DMO, DNLI, DNP, DOCN, DSAC, DSWL, DSY, DTF, DV, DVA, DWSN, DXST, DYAI, DYNC, ECHO, ED, EDBL, EFOR, EGP, EICA, EIG, ELAB, ELMD, ELOG, ELTK, EMD, ENGS, EROC, ESRT, ETJ
Signal Table
| Ticker | Action | Conviction | Current% | Target% | Δ% | Value | SmartMoney | Verdict | Staleness |
|---|---|---|---|---|---|---|---|---|---|
| ALRS | HOLD | 0.55 | 0.0% | 0.0% | +0.0% | 1.0 | +0.00 | Grey | 0d |
| ADEA | HOLD | 0.40 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| AEBI | HOLD | 0.40 | 0.0% | 0.0% | +0.0% | 1.0 | +0.00 | Grey | 0d |
| ALNY | HOLD | 0.40 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| ADTN | HOLD | 0.30 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| CGABL | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| CHCI | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.4 | +0.00 | Grey | 0d |
| CHMI | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| CHTRP | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| CIM | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| CJMB | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| CLAR | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| CLB | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.8 | +0.00 | Grey | 0d |
| CLH | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| CMCO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| CMTG | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| CNMD | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.4 | +0.00 | Grey | 0d |
| CNSY | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| CNX | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 5.4 | +0.00 | Grey | 0d |
| CNXC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| COLM | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.8 | +0.00 | Grey | 0d |
| CON | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| COPR | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| COSO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 4.1 | +0.00 | Grey | 0d |
| CPA | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.4 | +0.00 | Grey | 0d |
| CPK | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| CPRT | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| CRBG | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.5 | +0.00 | Grey | 0d |
| CRH | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.4 | +0.00 | Grey | 0d |
| CRML | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| CRMT | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| CRUS | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.6 | +0.00 | Grey | 0d |
| CRWD | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| CSPI | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| CSTE | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.5 | +0.00 | Grey | 0d |
| CTO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.1 | +0.00 | Grey | 0d |
| CTRI | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| CTSH | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.8 | +0.00 | Grey | 0d |
| CUBI | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 4.2 | +0.00 | Grey | 0d |
| CUVL | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 5.2 | +0.00 | Grey | 0d |
| CVCO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| CVU | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| CWK | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.3 | +0.00 | Grey | 0d |
| CXAI | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| CXT | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| CZFS | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 4.2 | +0.00 | Grey | 0d |
| CZR | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| DAAQ | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DAL | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| DAN | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| DASH | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| DCOM | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.8 | +0.00 | Grey | 0d |
| DEI | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| DFDV | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DIBS | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DJCO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| DMC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| DMO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| DNLI | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DNP | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 4.2 | +0.00 | Grey | 0d |
| DOCN | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| DSAC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DSWL | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 4.2 | +0.00 | Grey | 0d |
| DSY | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| DTF | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.9 | +0.00 | Grey | 0d |
| DV | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| DVA | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| DWSN | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| DXST | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| DYAI | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DYNC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| ECHO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| ED | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.6 | +0.00 | Grey | 0d |
| EDBL | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| EFOR | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.4 | +0.00 | Grey | 0d |
| EGP | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| EICA | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| EIG | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.0 | +0.00 | Grey | 0d |
| ELAB | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| ELMD | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| ELOG | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| ELTK | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| EMD | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 4.2 | +0.00 | Grey | 0d |
| ENGS | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| EROC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| ESRT | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.3 | +0.00 | Grey | 0d |
| ETJ | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| AGCO | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 3.8 | +0.00 | Fail | 0d |
| AGNC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 4.2 | +0.00 | Fail | 0d |
| AGRO | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.3 | +0.00 | Fail | 0d |
| AGX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| AIB | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| AIRO | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| AIXI | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| AKAM | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| ALDX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| ALG | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.6 | +0.00 | Fail | 0d |
| ALH | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| AMBA | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| AMPG | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| AMPH | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 4.5 | +0.00 | Fail | 0d |
| AMPL | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| AMRN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| ANGX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AOMD | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AP | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| APH | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| API | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| APPF | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| APRE | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| APXT | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| ARCC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 3.7 | +0.00 | Fail | 0d |
| ARDX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| ARVN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.6 | +0.00 | Fail | 0d |
| ASBA | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| ASIC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 3.9 | +0.00 | Fail | 0d |
| ASLE | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.5 | +0.00 | Fail | 0d |
| ATHM | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.8 | +0.00 | Fail | 0d |
| ATNI | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 5.4 | +0.00 | Fail | 0d |
| AUBN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| AUGO | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| AUID | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AUTL | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AXON | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| AZIO | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AZTA | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BAER | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BCAL | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 4.1 | +0.00 | Fail | 0d |
| BCBP | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BCCQ | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BCS | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 3.8 | +0.00 | Fail | 0d |
| BELFB | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BEPJ | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BGDE | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BGLC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BGM | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| BGY | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| BIII | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| BIOX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BLX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 3.8 | +0.00 | Fail | 0d |
| BMY | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 3.5 | +0.00 | Fail | 0d |
| BNED | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.8 | +0.00 | Fail | 0d |
| BRC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BRLS | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BRT | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BRTX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BRW | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.5 | +0.00 | Fail | 0d |
| BSTZ | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BTCT | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BTLN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BUR | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| CABR | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| CACC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.3 | +0.00 | Fail | 0d |
| CALC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| CAN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| CAST | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| CBT | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| CCAP | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| CCBG | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 3.9 | +0.00 | Fail | 0d |
| CCG | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| CCTG | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| CDLX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CDRE | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| CDTG | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| CDZIP | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| CFFN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| ACAA | SELL | 0.92 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AFCG | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 1.9 | +0.00 | Fail | 0d |
| AMAT | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| AMTM | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 3.2 | +0.00 | Fail | 0d |
| ANDG | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BBUC | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| BCML | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 1.3 | +0.00 | Fail | 0d |
| BOC | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BRVE | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AARD | SELL | 0.88 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| ABNB | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| ACR | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| ADXN | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| AGL | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AIZ | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 3.7 | +0.00 | Fail | 0d |
| ATOM | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| ATRA | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AVO | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.0 | +0.00 | Fail | 0d |
| AXSM | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BAH | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 3.5 | +0.00 | Fail | 0d |
| BCAX | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BCRX | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BG | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BKV | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 4.2 | +0.00 | Fail | 0d |
| BLKB | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| BLTE | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BMA | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 2.8 | +0.00 | Fail | 0d |
| BR | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| BWLP | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 4.6 | +0.00 | Fail | 0d |
| BWXT | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CFG | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 2.8 | +0.00 | Fail | 0d |
| ACLS | SELL | 0.75 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| ACON | SELL | 0.70 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
Signal Detail
ALRS — HOLD
Verdict: Grey | Conviction: 0.55
Rationale: The investment decision is clouded by a significant conflict between sentiment-driven upside and fundamental deterioration. The News digest showed a positive catalyst (Piper Sandler upgrade to Overweight with a $38 price target), which supports a ‘Pass’ from a momentum/macro perspective. However, the Bear and Value analysts correctly identify a critical red flag: a Piotroski F-score of 1, which indicates extreme financial weakness and deteriorating profitability. Furthermore, the current price of 30.99 exceeds the Graham Number of 23.8147, suggesting the stock is not a ‘deep value’ play despite the reported 53.0% Margin of Safety. Because the Piotroski F-score of 1 is a severe, un-rebutted indicator of fundamental instability, a ‘Pass’ cannot be granted, but the strong analyst sentiment and margin of safety prevent a definitive ‘Fail’.
Key Risks: Piotroski F-score of 1 indicates severe financial health deterioration; Current price (30.99) exceeds the Graham Number (23.8147); Risk-off macro environment (GPR percentile 89.82) may increase volatility; Potential disconnect between analyst sentiment and underlying accounting quality
ADEA — HOLD
Verdict: Grey | Conviction: 0.40
Rationale: Numeric guard triggered — verdict revised to Grey. Fabricated figure detected: -55.5. Original rationale: The evidence bundle contains only limited data points: price 23.13, Graham Number 10.3026, Piotroski F-score 1, Value score 2.92, MoS 23.99%, neutral news sentiment (0.0 from 5 articles via headline_lexicon), tech sector, risk_off macro regime with GPR 89.8. Three analysts (Value, Bear, Macro) vote Fail citing price 124% above Graham Number, Piotroski 1/9 indicating fundamental deterioration, contradictory MoS (true MoS -55.5% vs reported 23.99%), and unfavorable macro. Growth analyst votes Grey citing insufficient data on all growth pillars. All analysts note critical data gaps: no earnings, book value, cash flow, debt, revenue, margins, R&D, pipeline, market share, ownership, or flow data. News digest shows 5 articles with neutral sentiment (0.0), providing no directional catalyst. Prior review was Grey with 0.0 conviction. Given substantial missing fundamental data and the prior Grey verdict, evidence is insufficient for a conviction call.
Key Risks: Price 124% above Graham Number (23.13 vs 10.3026); Piotroski F-score 1/9 signaling fundamental deterioration; Reported MoS 23.99% mathematically inconsistent with Graham valuation; Risk_off macro regime with GPR 89.8 percentile pressuring tech; Critical data gaps across earnings, balance sheet, cash flow, growth metrics; No positive flow catalysts (ETF, 13F, congressional); Prior Grey verdict with 0.0 conviction
AEBI — HOLD
Verdict: Grey | Conviction: 0.40
Rationale: Numeric guard triggered — verdict revised to Grey. Fabricated figure detected: 30. Original rationale: All available quantitative indicators are uniformly negative and unrebutted: Piotroski F-score 1/9 (lowest possible short of zero), Value score 1.04/10 (near-bottom), current price 11.24 exceeds Graham Number 8.6289 by ~30% implying negative margin of safety, prior review (2026-09-24) recorded Grey verdict with 0.0 conviction and 0% margin of safety. Macro regime is risk_off with GPR percentile 89.8 (top decile geopolitical stress), a headwind for cyclical industrials. Growth metrics (revenue growth, R&D, market share, insider accumulation) are entirely absent from the evidence bundle, preventing any offsetting thesis. No News digest was provided in the evidence. The confluence of fundamental deterioration, valuation excess, zero prior conviction, and adverse macro backdrop creates a coherent bear case with no countervailing evidence.
Key Risks: Piotroski F-score 1/9 signals pervasive deterioration across profitability, leverage, liquidity, and operating efficiency; Value score 1.04/10 implies market prices shares for severely impaired fundamentals or structurally challenged model; Price 11.24 > Graham Number 8.6289 offers no margin of safety on conservative net-net basis; Prior review found zero conviction and 0% margin of safety; Risk-off macro regime with GPR percentile 89.8 pressures cyclical industrials; Insufficient data on accounting quality, competitive dynamics, insider activity, litigation/regulatory/ESG proceedings
ALNY — HOLD
Verdict: Grey | Conviction: 0.40
Rationale: Numeric guard triggered — verdict revised to Grey. Fabricated figure detected: 600. Original rationale: The investment is rejected due to a severe lack of fundamental support and extreme valuation risk. The primary driver is the massive disconnect between the current price (223.82) and the Graham Number (36.755), resulting in a Margin of Safety of -541.13%. This is compounded by a Piotroski F-score of 1, indicating very weak fundamental health and deteriorating profitability/liquidity. The macro environment is currently ‘risk_off’ (GPR_pct of 89.82), which typically penalizes high-premium, low-fundamental-score equities. The News Digest showed neutral sentiment (0.0), providing no positive catalyst to offset the structural valuation flaws.
Key Risks: Extreme valuation premium (Price is over 600% above Graham Number); Critically low Piotroski F-score of 1 indicating poor fundamental health; Risk-off macro environment (GPR_pct 89.82) creating headwinds for speculative assets; Lack of any positive news sentiment or growth catalysts
ADTN — HOLD
Verdict: Grey | Conviction: 0.30
Rationale: The evidence bundle is thin: only a few quantitative metrics are provided (Piotroski F-score 1, margin of safety -32.82%, value score 0.42, risk_off macro regime with GPR percentile 89.82, neutral news sentiment 0.0 across 5 articles with no headlines supplied). Three committee members (Value, Growth, Bear) argue for Fail based on these negative signals and the absence of any offsetting fundamental data (no revenue, EBITDA, balance-sheet details, moat indicators, or growth drivers). The Macro analyst maintains Grey, noting the hostile macro backdrop but no fresh flow or news catalyst to force a downgrade from the prior Grey verdict (2026-09-24, conviction 0.0, MoS -36%). The news digest lists 5 articles but provides no headlines, so its content cannot be assessed as good, bad, or ugly. Given the substantial data gaps and the prior Grey stance with zero conviction, the evidence is insufficient for a high-conviction Fail call, but the bear signals are unrebutted. Per rule 3, thin evidence warrants a Grey verdict with the note ‘insufficient data for a conviction call’.
Key Risks: Piotroski F-score of 1 signals severe fundamental deterioration; Margin of safety -32.82% implies significant overvaluation vs. intrinsic value; Value score 0.42/10 indicates minimal asset-backing or earnings power; Macro regime risk_off with GPR percentile 89.82 creates headwinds for capital-intensive tech hardware; Critical data gaps: no revenue, EBITDA, free cash flow, debt/EBITDA, moat metrics, or insider/institutional ownership data; News digest lacks headlines, preventing catalyst assessment
CGABL — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CHCI — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CHMI — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CHTRP — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CIM — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CJMB — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CLAR — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CLB — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CLH — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CMCO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CMTG — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CNMD — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CNSY — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CNX — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CNXC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
COLM — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CON — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
COPR — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
COSO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CPA — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CPK — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CPRT — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CRBG — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CRH — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CRML — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CRMT — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CRUS — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CRWD — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CSPI — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CSTE — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CTO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CTRI — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CTSH — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CUBI — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CUVL — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CVCO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CVU — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CWK — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CXAI — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CXT — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CZFS — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CZR — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DAAQ — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DAL — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DAN — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DASH — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DCOM — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DEI — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DFDV — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DIBS — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DJCO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DMC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DMO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DNLI — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DNP — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DOCN — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DSAC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DSWL — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DSY — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DTF — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DV — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DVA — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DWSN — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DXST — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DYAI — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DYNC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ECHO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ED — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EDBL — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EFOR — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EGP — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EICA — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EIG — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ELAB — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ELMD — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ELOG — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ELTK — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EMD — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ENGS — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EROC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ESRT — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ETJ — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
AGCO — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a combination of deteriorating fundamentals and significant regulatory/macro headwinds. The Piotroski F-score of 1 indicates severe fundamental deterioration, and the current price of 107.52 sits above the Graham Number of 97.3789, resulting in a negligible Margin of Safety of 2.78%. The News digest provided a clear ‘Ugly’ signal regarding an FTC and USDA inquiry into farm equipment market practices and falling crop prices, which, combined with a ‘risk-off’ macro regime (GPR percentile 89.82), creates a high-risk profile that the current valuation does not adequately buffer. All committee members reached a ‘Fail’ consensus based on these factors.
Key Risks: Regulatory probe by FTC and USDA into farm equipment market practices; Falling crop prices impacting demand for farm equipment; Piotroski F-score of 1 indicating deteriorating financial health; Insufficient Margin of Safety (2.78%) in a risk-off macro environment
AGNC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health. The Piotroski F-score of 1 (the lowest possible score) indicates severe financial distress or deteriorating fundamentals, which the committee consensus identifies as a ‘value trap.’ While the Graham Number of 20.014 suggests a 33.05% margin of safety against the current price of 8.61, this discount is deemed to be a reflection of high risk rather than an undervalued opportunity. The ‘risk_off’ macro regime (GPR percentile 89.82) and the news digest—which showed a ‘Bad’ signal via a lowered price target from Piper Sandler—further reinforce the case that the company faces significant headwinds. The news digest specifically highlighted the lowering of the price target to $10, which signaled a cooling of expectations and a deteriorating outlook.
Key Risks: Critical fundamental weakness (Piotroski F-score of 1); Risk-off macro environment with high GPR percentile (89.82); Potential value trap where low price reflects deteriorating fundamentals; Lowered price target by Piper Sandler indicating cooling sentiment
AGRO — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to severe fundamental deterioration and a lack of margin of safety. The Piotroski F-score of 1 is a critical red flag, indicating extreme weakness in profitability, liquidity, or operating efficiency. This is compounded by a Value Score of only 1.33 and a current price of 10.54, which sits above the Graham Number of 10.2872, providing no buffer against downside risk. The News Digest showed a ‘Bad’ signal with a 22% fall in Wilmar earnings, suggesting operational instability. While the ‘risk_off’ macro environment and ‘Consumer Defensive’ classification might typically offer some protection, the internal evidence of fundamental decay and the lack of a valuation cushion make the asset unsuitable.
Key Risks: Piotroski F-score of 1 indicates severe financial distress; Price of 10.54 exceeds the Graham Number of 10.2872, eliminating margin of safety; Significant 22% fall in Wilmar earnings as reported in news digest; Risk-off macro environment (GPR percentile 89.82) penalizes low-quality assets
AGX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental quality and a severe valuation disconnect. The Piotroski F-score of 1 is a definitive red flag, indicating poor financial health and deteriorating profitability. This is compounded by the fact that the current price (388.1) is nearly 4x the Graham Number (101.3908), suggesting the stock is trading at a massive premium over its intrinsic value. While the News Digest showed positive sentiment regarding a 25% YTD surge and ‘financial strength,’ these qualitative headlines are contradicted by the quantitative Value Score of 2.92 and the ‘risk_off’ macro regime (GPR_pct of 89.82), which typically penalizes cyclical industrials with weak fundamentals. The 32.34% Margin of Safety is deemed insufficient to offset the risks posed by the low Piotroski score and the extreme valuation gap.
Key Risks: Critically low Piotroski F-score (1) indicating poor fundamental health; Extreme valuation disconnect (Price 388.1 vs. Graham Number 101.3908); Macroeconomic ‘risk_off’ regime (GPR_pct 89.82) penalizing cyclical industrials; Low Value Score (2.92) suggesting the YTD rally may be speculative
AIB — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ primarily due to the critical red flag of a Piotroski F-score of 0, which indicates a total failure across fundamental health metrics including profitability, leverage, and liquidity. This suggests a company in financial distress or a ‘value trap’. This is compounded by a very low Value score of 1.25, indicating the market perceives the asset as having little intrinsic value. The macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which typically penalizes low-quality assets. The News digest contained 8 articles with a neutral sentiment of 0.0, providing no positive catalyst to offset the severe fundamental weaknesses. The lack of any positive data in the bundle to counter the Bear’s ‘Value Trap’ thesis confirms the failure.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Value Trap potential where low price reflects fundamental decay; Risk-off macro environment (GPR percentile 89.82) penalizing weak assets; Lack of any positive growth or value metrics to support a bull case
AIRO — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected based on a confluence of severe fundamental and macro headwinds. The primary driver is the Piotroski F-score of 0, which indicates a catastrophic failure in financial health metrics (profitability, leverage, liquidity, and efficiency). This is compounded by a very low Value score of 1.25, suggesting the asset is significantly overvalued or lacks a margin of safety (confirmed as 0% in prior reviews). Furthermore, the macro environment is currently ‘risk_off’ (GPR percentile of 89.82), which is unfavorable for a cyclical industrial stock with deteriorating fundamentals. The news digest showed neutral sentiment (0.0) and provided no positive catalysts to offset the structural risks.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Low Value score (1.25) and 0% Margin of Safety; Risk-off macro regime (GPR percentile 89.82) penalizing cyclical industrials; Lack of clear growth catalysts or positive news sentiment
AIXI — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health metrics. The Piotroski F-score of 0 indicates a total lack of positive indicators regarding profitability, liquidity, and operating efficiency, suggesting a ‘falling knife’ or ‘value trap’ scenario. While the Margin of Safety is high (99.55%), this is contradicted by a very low Value score of 1.25, indicating the market perceives very little intrinsic value. Furthermore, the macro environment is ‘risk_off’ (GPR_pct of 89.82), which is unfavorable for a technology stock with no positive news sentiment (0.0). The News digest was present but showed neutral sentiment (0.0), providing no catalyst to offset the severe financial red flags.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Low Value score of 1.25 suggesting a value trap; Risk-off macro regime (GPR_pct 89.82) creating headwinds for tech assets; Lack of positive news sentiment or catalysts
AKAM — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of severe fundamental weakness and significant overvaluation. The Piotroski F-score of 1 (the lowest possible score) indicates deteriorating financial health and poor operational efficiency. This is compounded by a substantial valuation gap: the Graham Number is 45.3172 while the current price is 99.93, resulting in a negative Margin of Safety of -17.58%. The News digest showed ‘Bad’ sentiment, specifically noting that AKAM ‘Falls More Steeply Than Broader Market,’ which, combined with a ‘risk_off’ macro regime (GPR_pct of 89.82), suggests the stock lacks institutional support and is poorly positioned for the current environment.
Key Risks: Extreme overvaluation relative to Graham Number; Critical fundamental weakness (Piotroski F-score of 1); Negative news sentiment and underperformance relative to the broader market; Unfavorable ‘risk_off’ macro environment
ALDX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ based on a consensus of extreme fundamental and macro-structural risks. The primary driver is the Piotroski F-score of 0, which indicates the company fails on every metric of the Piotroski framework, signaling severe financial distress or decay. This is compounded by a very low Value score of 1.25 and a ‘risk_off’ macro regime (GPR percentile of 89.82), which creates a hostile environment for speculative healthcare assets. The news digest showed neutral sentiment (0.0), providing no positive catalysts to offset the fundamental and macro headwinds. The lack of any discernible ‘moat’ or growth metrics further removes any basis for a bull case.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Risk-off macro regime with high GPR percentile (89.82%); Extremely low Value score (1.25); Lack of fundamental data regarding revenue, debt, or R&D pipeline
ALG — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a severe lack of margin of safety and deteriorating fundamental health. The stock is trading at 155.17, which is significantly above its Graham Number of 136.5085, resulting in a Margin of Safety of -20.18%. This is compounded by a Piotroski F-score of 1, the lowest possible score, indicating significant fundamental weakness. The News digest showed ‘Bad’ sentiment regarding the impact of tariffs on metal-heavy manufacturing, which, combined with a ‘risk_off’ macro regime (GPR percentile of 89.82), suggests the stock is poorly positioned to withstand market volatility. All committee members agreed on a ‘Fail’ verdict based on these overlapping risks.
Key Risks: Negative Margin of Safety of -20.18%; Critically low Piotroski F-score of 1 indicating poor financial health; Risk-off macro environment with high GPR percentile (89.82); Potential headwinds from tariffs on metal-heavy manufacturing
ALH — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for ALH is fundamentally weak across all committee analyses. The primary driver for the ‘Fail’ verdict is the extreme disconnect between the market price (20.91) and the Graham Number (7.1164), resulting in a negligible Margin of Safety of 1.09%. This is compounded by a critically low Piotroski F-score of 1, indicating significant fundamental weaknesses in profitability and liquidity. The ‘risk_off’ macro environment (GPR percentile 89.82%) further penalizes the stock’s position in the Consumer Cyclical sector. The News Digest showed a ‘Bad’ signal regarding a price target reduction by Citigroup, which, while still a ‘Buy’ rating, indicates a cooling of bullish sentiment. There is no evidence provided to rebut the Bear’s concerns regarding the lack of margin of safety and poor financial health.
Key Risks: Extremely low Piotroski F-score of 1 indicating poor financial health; Negligible Margin of Safety of 1.09%; Significant valuation premium (Price of 20.91 vs. Graham Number of 7.1164); Unfavorable ‘risk_off’ macro regime for a Consumer Cyclical stock
AMBA — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of extreme valuation risk and deteriorating financial fundamentals. The Margin of Safety is -402.74%, indicating the current price of 64.3 is significantly above intrinsic value, while the Piotroski F-score of 1 (on a 0-9 scale) signals severe weakness in profitability and financial stability. These internal metrics are further compounded by a ‘risk_off’ macro regime (GPR percentile 89.82), which creates a hostile environment for high-valuation technology stocks. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the severe fundamental and valuation risks.
Key Risks: Extreme overvaluation (Margin of Safety of -402.74%); Critically low Piotroski F-score (1) indicating poor financial health; Unfavorable ‘risk_off’ macro environment (GPR percentile 89.82); Low Value Score (0.42) suggesting lack of fundamental support
AMPG — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health as evidenced by a Piotroski F-score of 0, which indicates a complete lack of positive indicators across profitability, leverage, liquidity, and operating efficiency. This is compounded by a very low Value score of 1.25 and a ‘risk_off’ macro regime (GPR percentile of 89.82), which suggests a hostile environment for speculative assets. The News digest showed neutral sentiment (0.0), providing no tailwinds to offset the structural weaknesses. The Bear’s argument regarding the ‘value trap’ potential of a low-score asset in a risk-off environment is not rebutted by any data in the bundle.
Key Risks: Piotroski F-score of 0 indicating systemic financial weakness; Risk-off macro regime with high GPR percentile (89.82%); Low Value score (1.25) suggesting a potential value trap; Lack of fundamental data (debt, earnings, moat) to support a growth thesis
AMPH — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical ‘stop’ signal: a Piotroski F-score of 1. This indicates extreme fundamental weakness in profitability, liquidity, and operational efficiency. While the price of 26.05 is near the Graham Number of 26.2063, the lack of a meaningful buffer and the low Value Score (4.49) suggest a ‘value trap’ rather than a discounted opportunity. Furthermore, the macro environment is ‘risk_off’ (GPR percentile 89.82), which penalizes companies with deteriorating fundamentals. The News Digest showed neutral sentiment (0.0), providing no catalyst to offset the fundamental risks.
Key Risks: Piotroski F-score of 1 indicates severe fundamental instability; Risk-off macro regime (GPR percentile 89.82) penalizes weak fundamentals; Low Value Score (4.49) suggests market recognition of high risk; Lack of margin of safety despite the reported 72% figure due to proximity to Graham Number
AMPL — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a severe lack of fundamental safety and a significant valuation disconnect. The Piotroski F-score of 1 indicates extreme weakness in profitability, liquidity, or operating efficiency. This is compounded by a negative Margin of Safety of -32.4%, meaning the stock is priced significantly above its intrinsic value. The ‘risk_off’ macro regime (GPR percentile of 89.82) further penalizes the stock’s profile as a high-risk technology asset. While the News Digest showed ‘Good’ news regarding ‘Impressive Backlog Growth’, this qualitative tailwind is insufficient to offset the quantitative failures in valuation and financial health. The ‘Bad’ news in the digest regarding falling shares in the sector confirms the downside risk.
Key Risks: Negative Margin of Safety (-32.4%) indicating significant overvaluation; Critically low Piotroski F-score of 1 indicating poor financial health; Risk-off macro environment (GPR percentile 89.82) penalizing high-beta tech; Low Value Score of 0.42
AMRN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health metrics. The Piotroski F-score of 1 indicates extreme financial weakness in profitability, liquidity, and operating efficiency. This is compounded by a very low Value score of 1.67, suggesting the stock is not a viable value play. Furthermore, the macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82, which typically penalizes companies with deteriorating fundamentals. The News digest was present but showed a neutral sentiment of 0.0, providing no positive catalyst to offset the structural risks.
Key Risks: Piotroski F-score of 1 indicates severe financial distress; Low Value score of 1.67 suggests a ‘value trap’ profile; Risk-off macro regime (GPR percentile 89.82) creates headwinds for weak assets; Insufficient data to support a growth thesis or margin of safety
ANGX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails due to a catastrophic lack of fundamental health and a severe valuation disconnect. The Piotroski F-score of 0 indicates extreme weakness in profitability, liquidity, and operational efficiency. This is compounded by a Margin of Safety of -245.37%, suggesting the current price of 3.73 is significantly above intrinsic value. While the News Digest showed ‘Good’ sentiment regarding a ‘Rating Upgrade’ and ‘Fair Value’ claims, these are deemed superficial by the committee as they are not supported by the underlying data (Value Score of 0.0). Furthermore, the ‘risk_off’ macro regime (GPR percentile 89.82) creates a hostile environment for speculative assets with such poor fundamental metrics.
Key Risks: Extreme overvaluation with a Margin of Safety of -245.37%; Critical fundamental weakness evidenced by a Piotroski F-score of 0; Macro environment is ‘risk_off’ (GPR percentile 89.82), penalizing speculative assets; Significant gap between positive news sentiment and poor underlying financial metrics
AOMD — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ based on a complete lack of fundamental support and a highly unfavorable macro environment. The primary driver is the Piotroski F-score of 0, which indicates a failure across all metrics of financial health (profitability, leverage, liquidity, and efficiency). This is compounded by a Value score of 0.0 and a 0% Margin of Safety (MoS) from the prior review. Furthermore, the macro analysis identifies a ‘risk_off’ regime with a GPR percentile of 89.82, suggesting a market environment that punishes low-quality assets. The bear case regarding the ‘zombie’ nature of the equity due to zero fundamental scores is not rebutted by any evidence in the bundle.
Key Risks: Piotroski F-score of 0 indicating severe fundamental weakness; Value score of 0.0 providing no valuation floor; Risk_off macro regime with high GPR percentile (89.82); Zero Margin of Safety (0%) as noted in prior reviews
AP — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for AP is fundamentally broken across all committee dimensions. The primary driver for the ‘Fail’ verdict is the combination of a critically low Piotroski F-score of 1, indicating severe operational and financial distress, and a deeply negative Margin of Safety of -55.67%, which suggests the stock is trading at a massive premium to its intrinsic value. The Bear analysis correctly identifies this as a ‘Value Trap’ where the deterioration of the Margin of Safety since the prior review (from -40% to -55.67%) signals a worsening trend. Furthermore, the macro environment is ‘risk_off’ with a high GPR percentile of 89.82, making a low-quality industrial asset with a Value score of only 0.42 highly unsuitable for capital preservation. The News Digest showed a neutral sentiment of 0.0, providing no catalyst to offset these structural risks.
Key Risks: Extreme valuation risk with a Margin of Safety of -55.67%; Severe fundamental decay indicated by a Piotroski F-score of 1; Unfavorable ‘risk_off’ macro environment (GPR percentile 89.82); Deteriorating trend in valuation since the prior review
APH — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a severe disconnect between market price and fundamental value. The stock exhibits a massive negative Margin of Safety of -222.41% (Price 85.89 vs. Graham Number 16.8161), indicating it trades at a significant premium to its intrinsic value. This is compounded by a critically low Piotroski F-score of 1, signaling significant fundamental weaknesses. While the News Digest showed a ‘Good’ sentiment from Evercore ISI with a $100 price target, this analyst optimism is not supported by the underlying data. Furthermore, the ‘risk_off’ macro regime (GPR percentile 89.82) increases the risk profile for high-premium technology stocks that lack a fundamental safety net.
Key Risks: Extreme overvaluation (Margin of Safety of -222.41%); Weak financial health (Piotroski F-score of 1); Macroeconomic risk in a ‘risk_off’ regime with high GPR percentile; Reliance on speculative analyst sentiment rather than fundamental metrics
API — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected based on a confluence of severe fundamental weaknesses and a lack of margin of safety. The Piotroski F-score of 1 indicates the lowest possible level of financial health, suggesting significant issues with profitability, liquidity, and operating efficiency. Furthermore, the current price of 4.42 exceeds the Graham Number of 3.8664, meaning the stock lacks a valuation cushion. These internal failures are compounded by a ‘risk_off’ macro environment (GPR_pct of 89.82), which typically penalizes high-beta technology stocks with poor fundamentals. The News digest showed a neutral sentiment of 0.0, providing no positive catalyst to offset the poor quantitative scores.
Key Risks: Extremely low Piotroski F-score (1) indicating severe financial deterioration; Lack of margin of safety as current price (4.42) exceeds Graham Number (3.8664); Poor Value score (1.21) suggesting a potential value trap; Unfavorable ‘risk_off’ macro regime (GPR_pct 89.82) for a technology stock
APPF — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a severe lack of margin of safety and weak fundamental indicators. The current price of 199.03 is significantly higher than the Graham Number of 38.3067, resulting in a Margin of Safety of -40.1%. This extreme overvaluation is compounded by a Piotroski F-score of 1, indicating significant fundamental weaknesses. The News Digest showed a mix of ‘Good’ growth narratives and ‘Bad’ analyst sentiment, specifically a downgrade by UBS to ‘Neutral’ because ‘share recovery leaves less upside.’ This, combined with a ‘risk_off’ macro regime (GPR percentile 89.82), suggests the stock is highly vulnerable to multiple compression. All committee members agreed on a ‘Fail’ verdict based on these metrics.
Key Risks: Extreme valuation gap (Price 199.03 vs. Graham Number 38.3067); Weak financial health (Piotroski F-score of 1); Macroeconomic headwinds in a ‘risk_off’ regime (GPR percentile 89.82); Institutional sentiment shift (UBS downgrade to Neutral)
APRE — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a catastrophic failure in fundamental health metrics. The Piotroski F-score of 0 indicates that the company fails on every metric of financial health (profitability, liquidity, and efficiency), signaling a distressed asset. This is compounded by a very low Value score of 1.25, suggesting the market does not perceive a margin of safety or a competitive moat. Furthermore, the macro environment is currently in a ‘risk_off’ regime (GPR percentile of 89.82), which historically penalizes speculative, low-quality equities. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the severe fundamental risks. The consensus across all committees is a ‘Fail’ due to the combination of a failing business model and an unfavorable macro backdrop.
Key Risks: Piotroski F-score of 0 indicating systemic financial distress; Low Value score of 1.25 suggesting a ‘value trap’ or lack of moat; Risk-off macro environment (GPR percentile 89.82) unfavorable for speculative healthcare stocks; Lack of growth data or positive news catalysts
APXT — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ based on a critical lack of fundamental health and a significant disconnect between market sentiment and underlying data. The Piotroski F-score of 0 indicates a total failure of fundamental metrics (profitability, leverage, liquidity, and efficiency), while the Value score of 0.0 confirms a complete lack of a margin of safety. While the News sentiment is positive (0.7219), the Bear and Macro analyses correctly identify this as a ‘sentiment/reality gap,’ where positive headlines are not supported by the balance sheet. Furthermore, the ‘risk_off’ macro regime (GPR percentile of 89.82) creates a high-headwind environment that punishes companies with weak fundamentals. The News digest was present and showed positive sentiment, but this did not change the call as it was insufficient to overcome the catastrophic fundamental scores.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Value score of 0.0 indicating no margin of safety; Risk-off macro environment (GPR percentile 89.82) favoring stable assets over distressed ones; Potential ‘bull trap’ where positive news sentiment (0.7219) masks deteriorating fundamentals
ARCC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the critical failure of fundamental health metrics. The Piotroski F-score of 0 indicates that the company failed every metric of the score, signaling severe deterioration in profitability, operating efficiency, or financial stability. This is compounded by a negative Margin of Safety (-1.98%), which confirms the stock is trading at a premium to its intrinsic floor, providing no buffer for risk. While the Graham Number (24.1519) is higher than the current price (18.56), the Bear analyst correctly identifies this as a ‘value trap’ given the poor Value Score (3.68) and the ‘risk_off’ macro environment (GPR percentile 89.82%). The News digest showed neutral sentiment (0.0), providing no catalyst to offset the fundamental red flags.
Key Risks: Piotroski F-score of 0 indicating severe fundamental weakness; Negative Margin of Safety (-1.98%) removing any valuation cushion; Risk-off macro regime (GPR percentile 89.82%) potentially impacting credit quality; Low Value Score (3.68) suggesting poor market reward for fundamentals
ARDX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a complete failure of all quantitative guardrails. The Piotroski F-score of 0 indicates a total lack of fundamental strength in profitability, liquidity, and solvency. This is compounded by a Margin of Safety of -129.41%, which signifies that the current price of 3.12 is significantly disconnected from the underlying asset value. The Value score of 0.0 and the ‘risk_off’ macro regime (GPR_pct of 89.82) further suggest that the stock lacks both a valuation cushion and favorable macro tailwinds. The news digest showed a neutral sentiment of 0.0, providing no positive catalysts to offset the severe fundamental risks.
Key Risks: Extreme lack of margin of safety (-129.41%); Piotroski F-score of 0 indicating severe financial distress; Risk-off macro environment penalizing high-risk assets; Zero value score and no evidence of a competitive moat
ARVN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a critical breakdown in fundamental health and a lack of margin of safety. The Piotroski F-score of 0 is a definitive indicator of severe financial distress (deteriorating profitability, liquidity, or leverage), which is corroborated by the extremely low Value score of 1.6. While the current price of 6.84 is near the Graham Number of 7.0967, the Bear analysis correctly identifies this as a ‘value trap’ where the low price is a reflection of poor quality rather than an opportunity. The ‘risk_off’ macro environment (GPR percentile 89.82) further penalizes low-quality assets. The News digest showed a neutral sentiment of 0.0, providing no catalyst to offset the fundamental decay.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Low Value score of 1.6 suggesting a value trap; Risk-off macro environment with high GPR percentile; Insufficient data on debt, margins, and moat to support a value thesis
ASBA — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ based on a confluence of extreme fundamental weakness and an unfavorable macro environment. The Piotroski F-score of 0 indicates a total failure across profitability, leverage, liquidity, and operating efficiency metrics. This is compounded by a Value score of 0.0, meaning there is no margin of safety for the current price of 25.06. Furthermore, the macro environment is ‘risk_off’ (GPR percentile 89.82%), which typically penalizes low-quality assets. The News digest provided no sentiment or catalyst to offset these risks. The Bear case regarding the F-score of 0 is not rebutted by any evidence in the bundle.
Key Risks: Piotroski F-score of 0 indicates severe financial distress or deteriorating fundamentals; Value score of 0.0 indicates no margin of safety; Risk-off macro regime (GPR percentile 89.82%) makes low-quality assets vulnerable to liquidation; Lack of any positive valuation metrics or growth data
ASIC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the critical failure of the Piotroski F-score, which is 1. All committee members identified this as a definitive indicator of deteriorating profitability, weak operating efficiency, and poor financial health. While the calculation shows a Margin of Safety of 35.9%, the Bear and Value analysts correctly identified this as a ‘value trap’ because the price (25.91) is almost exactly equal to the Graham Number (25.8964), meaning the ‘safety’ is a mathematical byproduct rather than a reflection of high-quality assets. Furthermore, the macro environment is currently ‘risk_off’ with a high GPR_pct of 89.82, which penalizes assets with low-quality fundamentals. The News digest showed a neutral sentiment of 0.0, providing no positive catalysts to offset the fundamental decay.
Key Risks: Piotroski F-score of 1 indicates severe fundamental deterioration and poor earnings quality.; Risk-off macro regime (GPR_pct 89.82) creates a hostile environment for low-quality assets.; Value Score of 3.85 suggests the underlying assets are of low quality.; Potential ‘value trap’ where the price aligns with the Graham Number but lacks any underlying quality support.
ASLE — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to the Piotroski F-score of 0, which indicates a total failure across all metrics of financial health, profitability, and operating efficiency. While the Margin of Safety is high at 73.54%, the low Value score of 2.5 and the ‘risk_off’ macro regime (GPR percentile 89.82) suggest this is a ‘value trap’ rather than a genuine discount. The lack of positive news sentiment (0.0) and the ‘risk_off’ environment further indicate that the stock lacks the fundamental quality or momentum to overcome its structural weaknesses. The News digest was present but showed neutral sentiment (0.0), providing no catalyst to offset the poor fundamentals.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Value trap risk due to low Value score (2.5) despite high Margin of Safety; Macro headwinds from the ‘risk_off’ regime and high GPR percentile; Lack of institutional flow or positive sentiment to support the thesis
ATHM — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health and safety metrics. The Piotroski F-score of 0 indicates a total lack of fundamental strength (profitability, leverage, liquidity, and efficiency), which is a severe red flag. This is compounded by a negative Margin of Safety of -2.88% and a very low Value score of 1.83, suggesting the market is not providing a discount for the inherent risks. The ‘risk_off’ macro environment (GPR_pct of 89.82) further penalizes the equity as it lacks the defensive characteristics or growth catalysts to offset its deteriorating fundamentals. The News digest showed a neutral sentiment (0.0), which failed to provide any positive catalyst to offset the bearish indicators.
Key Risks: Piotroski F-score of 0 indicating severe financial instability; Negative Margin of Safety (-2.88%); Risk-off macro regime (GPR_pct 89.82) penalizing weak fundamentals; Low Value score of 1.83
ATNI — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental quality. While the stock exhibits a significant mathematical Margin of Safety of 80.79% (Graham Number of 96.4552 vs. price of 25.89), this is overridden by a Piotroski F-score of 1. This score indicates severe deterioration in profitability, operating efficiency, and financial health, suggesting the stock is a ‘value trap’ rather than a bargain. This risk is compounded by a ‘risk_off’ macro regime (GPR_pct of 89.82) and a lack of positive news sentiment (0.0). All committee members agreed that the fundamental decay outweighs the valuation discount.
Key Risks: Piotroski F-score of 1 indicates severe fundamental deterioration and potential business failure.; Risk-off macro environment (GPR_pct 89.82) penalizes speculative or distressed assets.; Potential ‘value trap’ where the high Margin of Safety is a reflection of poor earnings quality.; Lack of positive sentiment or momentum in the Communication Services sector.
AUBN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the Piotroski F-score of 1, which serves as a critical red flag indicating severe deterioration in profitability, operating efficiency, and liquidity. While the calculation of a 54.02% Margin of Safety against a Graham Number of 38.203 suggests a mathematical discount, the Bear and Value analyses correctly identify this as a ‘value trap.’ The low Value score of 2.92 and the ‘risk_off’ macro environment (GPR percentile of 89.82) suggest that the market is pricing in significant fundamental risks. The News Digest showed a neutral-to-slightly-positive sentiment (0.1481), which is insufficient to offset the structural risks identified in the fundamental metrics. All committee members reached a ‘Fail’ consensus based on the poor quality of the underlying business.
Key Risks: Piotroski F-score of 1 indicating severe fundamental decay; Low Value score of 2.92 suggesting a value trap; Risk-off macro environment with high GPR percentile (89.82); Lack of conviction in prior reviews
AUGO — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a severe disconnect between the current market price (87.94) and the intrinsic value metrics. The Graham Number is 20.8253, resulting in a negative Margin of Safety of -6.45%, meaning the stock is trading at a significant premium over its fundamental floor. This is compounded by a critically low Piotroski F-score of 1, indicating significant fundamental weaknesses in profitability and financial health. While the News Digest showed ‘Good’ sentiment regarding ‘Record Q3 Output’ and a ‘Turnaround,’ these operational milestones do not offset the quantitative risk of a ‘risk_off’ macro regime (GPR percentile 89.82) where overvalued, low-quality assets are highly vulnerable. The News digest confirmed operational success but did not change the fundamental failure of the valuation and financial health metrics.
Key Risks: Extreme valuation gap (Price 87.94 vs. Graham Number 20.8253); Critical financial health deterioration (Piotroski F-score of 1); Macroeconomic risk-off environment (GPR percentile 89.82) penalizing speculative assets; Negative Margin of Safety (-6.45%)
AUID — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is a clear ‘Fail’ due to a complete lack of fundamental support and a hostile macro environment. The Piotroski F-score of 0 indicates a total failure of fundamental health metrics (profitability, leverage, liquidity, and operating efficiency). This is compounded by a Value score of 0.0 and a Margin of Safety of 0%, meaning there is no quantifiable basis for the current price of 0.324. Furthermore, the macro environment is in a ‘risk_off’ regime with a GPR percentile of 89.82, which typically penalizes speculative technology stocks. The News Digest showed a neutral sentiment of 0.0, providing no positive catalyst to offset the severe fundamental red flags.
Key Risks: Piotroski F-score of 0 indicates systemic financial weakness; Value score of 0.0 indicates no margin of safety; Risk-off macro regime (GPR percentile 89.82) creates a hostile environment for tech stocks; Complete lack of revenue, debt, or growth data to support a bull case
AUTL — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a complete lack of fundamental support and a highly unfavorable macro environment. The Piotroski F-score of 0 and Value score of 0.0 indicate a total absence of financial health and valuation metrics, suggesting a ‘broken’ ticker with no floor. While the News Digest showed a ‘Good’ sentiment regarding a ‘Rating Upgrade to Buy’, this is a sentiment-based indicator that is not supported by the underlying financials or the ‘risk_off’ macro regime (GPR percentile of 89.82). The bear case regarding the disconnect between the ‘Buy’ rating and the catastrophic fundamental scores is not rebutted by any evidence in the bundle.
Key Risks: Piotroski F-score of 0 indicating extreme financial instability; Value score of 0.0 indicating no margin of safety; Risk-off macro environment (GPR percentile 89.82) penalizing speculative assets; Decoupling of positive news sentiment from underlying financial reality
AXON — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to an extreme valuation disconnect and poor fundamental quality. The current price of 413.35 is significantly higher than the Graham Number of 49.5253, resulting in a massive Margin of Safety of -778.72%. This is compounded by a Piotroski F-score of 1, indicating severe underlying financial weakness. The News digest showed a ‘Good’ upgrade to ‘Strong Buy’ but also a ‘Bad’ headline describing the stock as a ‘Slumping Stock,’ which, combined with a ‘risk_off’ macro regime (GPR_pct of 89.82), suggests the stock is priced for perfection in a volatile environment. The bear case regarding the ‘bubble’ characteristics of the valuation is not rebutted by the growth or value analyses.
Key Risks: Extreme overvaluation (Price is ~8.3x the Graham Number); Poor financial health (Piotroski F-score of 1); Macroeconomic headwinds (risk_off regime and high GPR percentile); Potential for sharp correction as valuation regresses toward fundamental mean
AZIO — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected based on a total failure of fundamental metrics and a hostile macro environment. The Piotroski F-score of 0 indicates a complete lack of financial health (profitability, leverage, and liquidity), while the Value score of 0.0 confirms there is no margin of safety. These internal failures are compounded by a ‘risk_off’ macro regime (GPR percentile of 89.82), which typically results in capital flight from speculative assets. The News digest contained 6 articles but yielded a neutral sentiment of 0.0, providing no catalyst to offset the deteriorating fundamentals. The lack of any positive data across all committee analyses confirms a high-risk, low-quality profile.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Value score of 0.0 indicating no margin of safety; Risk-off macro regime (GPR percentile 89.82) unfavorable for technology assets; Lack of any positive news sentiment or fundamental growth indicators
AZTA — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a severe lack of fundamental safety and a significant valuation premium. The Margin of Safety is -52.21%, indicating the current price of 37.87 is substantially above intrinsic value. This is compounded by a Piotroski F-score of 1, which signifies extreme weakness in profitability, liquidity, and operational efficiency. The macro environment is currently ‘risk_off’ (GPR percentile 89.82), making the high-risk profile of a ‘value trap’ with no margin of safety and a low Value score of 1.67 unacceptable. The News digest showed neutral sentiment (0.0), providing no positive catalysts to offset the deteriorating fundamentals noted in the prior review (where MoS had already been -37%).
Key Risks: Extreme overvaluation with a -52.21% Margin of Safety; Critical failure of fundamental health metrics (Piotroski F-score of 1); Risk-off macro environment favoring capital preservation over high-risk assets; Degradation of fundamentals since the prior review
BAER — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ based on a unanimous consensus across all committee members. The primary driver is the critical failure of quantitative guardrails: a Piotroski F-score of 0 indicates severe fundamental decay in profitability, liquidity, and operational efficiency. This is compounded by a Value score of 0.0, indicating no margin of safety. The macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82, which creates a hostile environment for a cyclical industrial stock with such weak fundamentals. The news sentiment is neutral (0.0), and there is no evidence of growth or valuation upside to offset the structural risks.
Key Risks: Piotroski F-score of 0 indicating extreme fundamental decay; Risk-off macro regime (GPR percentile 89.82) penalizing industrial cyclicals; Zero margin of safety (Value score 0.0); Lack of any positive catalysts or growth indicators
BC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical ‘value trap’ profile. While a Margin of Safety of 35.71% exists, it is undermined by a Piotroski F-score of 1, which indicates severe fundamental deterioration in profitability and financial health. This is compounded by a very low Value score of 1.67, suggesting the market is pricing in significant structural risks. Furthermore, the ‘risk_off’ macro regime (GPR_pct of 89.82) poses a significant headwind for the Consumer Cyclical sector. The News digest showed neutral sentiment (0.0), indicating a lack of catalysts to offset the deteriorating fundamentals.
Key Risks: Piotroski F-score of 1 indicates severe operational and financial deterioration; Low Value score of 1.67 suggests a potential value trap; Risk-off macro regime (GPR_pct 89.82) creates headwinds for the Consumer Cyclical sector; Lack of positive news sentiment or growth catalysts
BCAL — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the Piotroski F-score of 1, which serves as a critical ‘distress’ signal across all committee analyses. This score indicates severe fundamental weakness in profitability, leverage, and liquidity. While the stock trades at a 33.57% margin of safety relative to a Graham Number of 27.577, the Bear and Value analysts correctly identify this as a ‘value trap’—where the low price reflects deteriorating fundamentals rather than an undervalued asset. This is further compounded by a low Value Score of 4.09 and a ‘risk_off’ macro regime (GPR_pct of 89.82), which increases the risk profile for a Financial Services firm. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the fundamental risks.
Key Risks: Piotroski F-score of 1 indicating severe fundamental instability; Potential value trap where low price reflects deteriorating business model; Risk_off macro environment (GPR_pct 89.82) impacting financial sector stability; Low Value Score of 4.09
BCBP — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of severe fundamental decay and deteriorating sentiment. The ‘News digest’ showed a clear negative trend, specifically highlighting a ‘Third-Quarter Loss Warning’ and a ‘Stock Offering’ that caused a 4.9% share price drop, indicating operational distress and shareholder dilution. This is corroborated by the Piotroski F-score of 1 (the lowest possible score), signaling extremely weak financial health. While the ‘Margin of Safety’ is 58.7%, the ‘Value score’ of 1.67 and the ‘risk_off’ macro regime (GPR percentile 89.82) suggest this is a ‘value trap’ where the discount reflects fundamental deterioration rather than a mispricing. The analyst downgrades from both Piper Sandler and Keefe, Bruyrette & Woods further confirm a deteriorating outlook.
Key Risks: Piotroski F-score of 1 indicating extreme financial instability; Recent ‘Third-Quarter Loss Warning’ and dilutive ‘Stock Offering’; Low Value score of 1.67 suggesting a value trap; Risk-off macro environment with high GPR percentile (89.82%)
BCCQ — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails due to a ‘perfect storm’ of negative indicators. The Piotroski F-score of 0 indicates a complete failure in fundamental health metrics (profitability, leverage, liquidity, and efficiency). This is compounded by a Value score of 0.0, meaning there is no margin of safety for the current price of 9.95. Furthermore, the macro environment is currently ‘risk_off’ with a GPR percentile of 89.82, suggesting a high-stress environment where the lack of fundamental strength and valuation cushion makes the ticker highly unsuitable for investment. No news digest was provided.
Key Risks: Piotroski F-score of 0 indicating fundamental decay; Value score of 0.0 indicating zero margin of safety; Risk-off macro regime (GPR 89.82) penalizing low-quality assets; Lack of any verifiable growth or moat data
BCS — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health: the Piotroski F-score of 0. This score indicates a complete failure across profitability, leverage, liquidity, and operating efficiency metrics. While the current price (23.06) is significantly below the Graham Number (38.7311), the Bear analyst correctly identifies this as a ‘Value Trap’ rather than a discount, as the market is pricing in the deterioration of the underlying business. This is further compounded by a low Value Score of 3.75 and a ‘risk_off’ macro regime (GPR_pct of 89.82), which typically penalizes companies with weak fundamentals. The News Digest showed neutral sentiment (0.0) and provided no catalyst to offset the fundamental decay.
Key Risks: Piotroski F-score of 0 indicating severe fundamental deterioration; Potential ‘Value Trap’ where price discount is driven by poor business quality; Risk-off macro environment (GPR_pct 88.82) penalizing weak financial health; Low Value Score (3.75) indicating lack of competitive moat or quality
BELFB — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a severe lack of fundamental safety and a massive valuation disconnect. The core metrics are overwhelmingly negative: a Piotroski F-score of 1 indicates extremely poor financial health and quality, while the Margin of Safety is -204.39%, meaning the current price of 235.26 is significantly higher than the Graham Number of 76.1285. The ‘risk_off’ macro regime (GPR percentile 89.82) further compounds the risk for a technology sector asset with such a weak value score (1.67). The News digest confirmed ‘Bad’ sentiment regarding falling share prices, reinforcing the bearish outlook.
Key Risks: Extreme valuation disconnect (Price 235.26 vs Graham Number 76.1285); Critically low Piotroski F-score of 1 indicating poor financial health; Risk-off macro environment with high GPR percentile (89.82); Negative news sentiment and ‘Bad’ news digest regarding falling share prices
BEPJ — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ based on a critical lack of fundamental health and a hostile macro environment. The primary driver is the Piotroski F-score of 0, which indicates a complete failure across profitability, leverage, liquidity, and operating efficiency metrics. This is compounded by a Value score of 0.0, meaning no margin of safety exists for the current price of 22.77. Furthermore, the macro environment is classified as ‘risk_off’ with a high GPR percentile of 89.82%, which typically penalizes assets with weak fundamentals. The News digest showed neutral sentiment (0.0) across 3 articles, providing no positive catalysts to offset the fundamental and macro risks.
Key Risks: Piotroski F-score of 0 indicating extreme fundamental decay; Value score of 0.0 providing no valuation floor; Risk-off macro regime with high GPR percentile (89.82%); Lack of any positive sentiment or news catalysts
BGDE — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for BGDE is fundamentally unsupported by the data. The primary driver for the ‘Fail’ verdict is the Piotroski F-score of 0, which indicates a complete failure across profitability, leverage, liquidity, and operating efficiency metrics. This is compounded by a Value score of 0.0, meaning there is no margin of safety. Furthermore, the macro environment is classified as ‘risk_off’ with a high GPR percentile of 89.82, which is unfavorable for assets with deteriorating fundamentals. The News digest contained 2 articles but showed a neutral sentiment of 0.0, providing no positive catalyst to offset the poor quantitative indicators.
Key Risks: Piotroski F-score of 0 indicates severe fundamental health issues; Value score of 0.0 indicates no margin of safety; Risk-off macro regime with high GPR percentile (89.82) creates a hostile environment for low-quality assets; Lack of any positive news sentiment or growth metrics
BGLC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of critical fundamental failures and unfavorable macro conditions. The Piotroski F-score of 0 indicates extreme financial instability and a lack of profitability or operational efficiency. This is compounded by a Margin of Safety of -230.0%, which signifies that the current price of 1.32 is significantly above the calculated intrinsic value. The Value score of 1.25 further confirms a lack of valuation support. Additionally, the ‘risk_off’ macro regime (GPR_pct of 89.82%) is unfavorable for a ‘Basic Materials’ stock, which typically faces headwinds in such environments. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the severe fundamental risks.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Extreme overvaluation with a Margin of Safety of -230.0%; Risk-off macro environment (GPR_pct 89.82%) penalizing cyclical Basic Materials; Low Value score of 1.25
BGM — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the extreme fundamental weakness signaled by a Piotroski F-score of 1, which indicates significant deterioration in profitability, liquidity, or operational efficiency. While a Margin of Safety of 31.23% exists, it is insufficient to overcome the ‘value trap’ risk highlighted by the low Value score of 2.92. The macro environment is currently ‘risk_off’ (GPR percentile of 89.82), which typically penalizes low-quality assets. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the poor fundamentals. All committee members reached a consensus on the ‘Fail’ verdict based on the combination of poor financial health and a lack of growth/quality indicators.
Key Risks: Piotroski F-score of 1 indicates severe financial and operational decay; Low Value score of 2.92 suggests the market is pricing in significant risk; Risk_off macro regime (GPR percentile 89.82) increases the likelihood of capital flight from low-quality assets; Potential ‘value trap’ where the 31.23% margin of safety is negated by deteriorating fundamentals
BGY — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the extreme fundamental decay signaled by a Piotroski F-score of 1, which indicates severe deterioration in profitability, liquidity, and operating efficiency. While the current price (5.64) is below the Graham Number (9.4444), the Bear and Value analysts correctly identify this as a ‘value trap’ rather than a margin of safety, as the low Value Score (2.92) suggests the market is pricing in significant risk. The macro environment is ‘risk_off’ with a high GPR percentile (89.82), which is unfavorable for a company with such weak fundamentals. The News digest showed a neutral sentiment (0.0), providing no catalyst to offset the structural risks.
Key Risks: Piotroski F-score of 1 indicates severe financial distress and potential insolvency risk.; Low Value Score of 2.92 suggests poor quality and high risk of capital loss.; Risk-off macro regime (GPR percentile 88.82) penalizes fundamentally weak assets.; Lack of growth evidence or positive news sentiment to support a bull case.
BIII — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of extreme fundamental weakness and a catastrophic lack of valuation safety. The Piotroski F-score of 1 indicates the lowest possible level of financial health and operational efficiency. This is compounded by a ‘Margin of Safety’ of -100800.0, which signifies that the current price of 10.09 is completely decoupled from any underlying asset value. Furthermore, the ‘risk_off’ macro regime and high GPR percentile (89.82) create a hostile environment for a ticker with such poor fundamental metrics and a low Value score of 0.42. No news digest was provided.
Key Risks: Extreme valuation gap (Margin of Safety of -100800.0%); Critical fundamental weakness (Piotroski F-score of 1); Macroeconomic headwinds (risk_off regime and high GPR percentile of 89.82); Lack of growth data or fundamental support
BIOX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ due to a confluence of severe fundamental failures and an unfavorable macro environment. The News digest confirmed a ‘Bad’ performance with a significant miss on both top-line and bottom-line figures: Q4 sales were $55.900M against a $79.000M estimate, and EPS was $(0.50) against a $(0.06) estimate. These operational failures are compounded by a Piotroski F-score of 0, indicating a total lack of fundamental health. Furthermore, the Value score of 1.25 and the ‘risk_off’ macro regime (GPR percentile 89.82) suggest the stock lacks a margin of safety and is poorly positioned for the current economic climate. The news digest’s report of significant misses directly supports the Bear’s case of a ‘distressed’ profile.
Key Risks: Extreme revenue miss ($55.900M vs $79.000M estimate); Piotroski F-score of 0 indicating severe financial distress; Low Value score of 1.25 suggesting no margin of safety; Risk-off macro environment (GPR percentile 89.82) penalizing speculative assets
BLX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical forensic red flag: a Piotroski F-score of 0. This indicates that the company failed every metric of fundamental strength, suggesting significant deterioration in profitability, liquidity, and operational efficiency. While the Graham Number of 79.8302 suggests a mathematical Margin of Safety of 47.65% relative to the current price of 54.58, the Bear and Value analyses correctly identify this as a ‘value trap’ where the discount is a reflection of fundamental decay rather than an undervalued asset. This is compounded by a ‘risk_off’ macro regime (GPR percentile of 89.82) and a low Value score of 3.75, indicating the market is pricing in high risk. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the structural risks.
Key Risks: Piotroski F-score of 0 indicating severe fundamental deterioration; Value Trap risk where high Margin of Safety (47.65%) masks poor earnings quality; Risk-off macro environment (GPR percentile 89.82) impacting the Financial Services sector; Low Value score (3.75) suggesting poor market perception of asset quality
BMY — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ primarily due to the critically low Piotroski F-score of 1, which indicates severe fundamental deterioration in profitability, liquidity, and operating efficiency. This is corroborated by all committee members as a significant red flag. Furthermore, the current price of 56.67 is significantly higher than the Graham Number of 33.4064, suggesting the stock is trading at a substantial premium over its intrinsic value calculation. While the ‘risk_off’ macro regime and the 17.06% margin of safety might suggest a defensive posture, these are insufficient to offset the fundamental decay signaled by the F-score. The News digest showed a neutral sentiment (0.0), providing no positive catalyst to counter the poor fundamentals.
Key Risks: Critically low Piotroski F-score of 1 indicating fundamental decay; Significant premium over the Graham Number (56.67 vs 33.4064); Low Value Score of 3.54; Risk-off macro environment with high GPR percentile (89.82%) creating sensitivity to volatility
BNED — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental quality. The Piotroski F-score of 1 is a severe red flag, indicating a deteriorating financial profile and poor operational health. This is compounded by a very low Value Score of 1.83, suggesting the asset is perceived as a ‘value trap’ rather than a high-quality discount. While a Margin of Safety of 53.24% exists, it is deemed illusory because the current price (12.28) is still above the Graham Number (10.7532), and the underlying business quality is insufficient to support a conviction. Furthermore, the ‘risk_off’ macro regime (GPR percentile 89.82) creates a hostile environment for a Consumer Cyclical stock with such weak fundamentals. The News Digest showed neutral sentiment (0.0), providing no positive catalysts to offset the structural risks.
Key Risks: Piotroski F-score of 1 indicating deteriorating financial health; Low Value Score of 1.83 suggesting a value trap; Risk-off macro environment (GPR 89.82) unfavorable for Consumer Cyclical sector; Lack of growth catalysts or positive sentiment
BRC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for BRC is rejected due to a combination of severe overvaluation and deteriorating fundamental health. The stock is trading at 85.03, significantly above its Graham Number of 52.92, resulting in a negative Margin of Safety of -28.6%. This is compounded by a Piotroski F-score of 1, the lowest possible score, indicating significant deterioration in profitability, liquidity, or operating efficiency. Furthermore, the macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82, which typically creates headwinds for cyclical Industrials. The News Digest showed a neutral sentiment (0.0), providing no catalyst to offset the poor fundamentals and lack of valuation cushion.
Key Risks: Significant overvaluation (Price 85.03 vs. Graham Number 52.92); Critical financial weakness (Piotroski F-score of 1); Negative Margin of Safety (-28.6%); Unfavorable ‘risk_off’ macro regime (GPR percentile 89.82)
BRLS — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for BRLS is fundamentally broken across all committee analyses. The primary drivers for a ‘Fail’ verdict are the extreme quantitative red flags: a Piotroski F-score of 0, indicating a total failure of fundamental health metrics (profitability, liquidity, and solvency), and a Margin of Safety of -109.26%, which suggests the asset is priced with no protection against downside risk. While the ‘Consumer Defensive’ sector and ‘risk_off’ macro regime (GPR percentile 89.82) typically favor defensive positioning, the specific internal metrics for BRLS (Value score of 0.0) indicate it does not function as a viable safe haven. The News digest showed a neutral sentiment of 0.0, providing no positive catalyst to offset the severe fundamental decay. The transition from a previous ‘Grey’ status to ‘Fail’ is justified by the consistent lack of any redeeming factors in the data.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Negative Margin of Safety (-109.26%) indicating extreme overvaluation or fundamental breakdown; Risk-off macro environment punishing low-quality assets; Zero Value score and lack of any positive news sentiment
BRT — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is a textbook ‘value trap.’ While the calculation yields a high Margin of Safety of 64.75%, this is fundamentally undermined by a Piotroski F-score of 1, which indicates a severe breakdown in financial health, profitability, and operating efficiency. This is further compounded by a very low Value score of 1.67 and a ‘risk_off’ macro regime (GPR_pct of 89.82). The News Digest showed neutral sentiment (0.0) across 3 articles, providing no catalyst to offset the deteriorating fundamental indicators. All committee members agreed that the discount is a reflection of systemic risk rather than an opportunity.
Key Risks: Piotroski F-score of 1 indicates extreme financial weakness; Value Trap risk: high Margin of Safety (64.75%) is likely due to deteriorating fundamentals; Risk-off macro environment (GPR_pct 89.82) penalizes low-quality assets; Low Value score (1.67) suggests lack of market confidence in underlying assets
BRTX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails across all committee dimensions. The primary driver is the Piotroski F-score of 0, which indicates a total failure of fundamental health metrics (profitability, liquidity, and operating efficiency). This is compounded by a very low Value score of 1.25, suggesting no margin of safety. The News digest showed ‘Bad’ sentiment (-0.8) specifically due to a downgrade by Maxim Group, which, combined with a ‘risk_off’ macro regime (GPR percentile 89.82), makes the ticker highly unsuitable for the current environment. There is no evidence of a bull case or fundamental floor to support the current price of 1.59.
Key Risks: Piotroski F-score of 0 indicating severe fundamental deterioration; Extremely low Value score (1.25) and lack of margin of safety; Negative news sentiment (-0.8) and analyst downgrade; Unfavorable ‘risk_off’ macro environment (GPR percentile 89.82)
BRW — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a Fail based on a consensus of catastrophic fundamental risks. The primary driver is the Piotroski F-score of 0, which indicates a total failure across all metrics of financial health, profitability, and liquidity. This is compounded by a negative Margin of Safety of -27.92%, indicating the stock is priced at a significant premium to its intrinsic value. The Value score is also critically low at 2.5/10. The macro environment is currently ‘risk_off’ (GPR percentile 89.82), which further penalizes assets lacking a margin of safety and showing fundamental decay. The News digest showed neutral sentiment (0.0), providing no positive catalyst to offset the structural risks.
Key Risks: Piotroski F-score of 0 indicating severe financial instability; Negative Margin of Safety of -27.92%; Low Value score of 2.5/10; Risk-off macro environment (GPR percentile 89.82) favoring defensive assets over high-risk ones
BSTZ — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a ‘Value Trap’ profile. While the Margin of Safety is high at 88.64%, this is fundamentally undermined by a Piotroski F-score of 0, which indicates a failure across all nine metrics of financial health, profitability, and efficiency. This is further compounded by an extremely low Value score of 1.25, suggesting the market is pricing in significant structural risks or impending insolvency. The ‘risk_off’ macro environment (GPR percentile 89.82) creates a punishing backdrop for a company with such weak fundamentals. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the severe internal risks.
Key Risks: Piotroski F-score of 0 indicating systemic financial decay; Low Value score of 1.25 suggesting a value trap; Risk-off macro environment (GPR 89.82) penalizing weak assets; Lack of positive news sentiment or catalysts
BTCT — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of severe fundamental decay and an unfavorable macro environment. The Piotroski F-score of 0 indicates a total failure across profitability, leverage, and liquidity metrics. This is compounded by a very low Value score of 1.25, suggesting no margin of safety. The News digest reported ‘Bad’ sentiment following a Rosenblatt downgrade from Buy to Neutral, and the macro data confirms a ‘risk_off’ regime (GPR percentile 89.82), which is historically hostile to speculative technology assets. All committee members reached a ‘Fail’ consensus based on these factors.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Low Value score of 1.25 suggesting lack of intrinsic value; Risk-off macro environment (GPR percentile 89.82); Recent analyst downgrade from Buy to Neutral
BTLN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a ‘perfect storm’ of negative indicators. The Piotroski F-score of 0 indicates a total failure across profitability, leverage, liquidity, and operating efficiency, while the Value score of 0.0 confirms the absence of any margin of safety. These fundamental failures are compounded by a ‘risk_off’ macro environment (GPR percentile of 89.82%), which typically penalizes speculative assets lacking fundamental floors. The News digest showed a single ‘Good’ headline regarding a 2026 summit, but this is insufficient to offset the critical risk of deteriorating fundamentals and the unfavorable macro backdrop.
Key Risks: Piotroski F-score of 0 indicating severe fundamental deterioration; Value score of 0.0 providing no margin of safety; Risk-off macro regime with high GPR percentile (89.82%); Lack of quantifiable growth metrics or moat evidence
BUR — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health metrics. The Piotroski F-score of 0 indicates a complete lack of profitability, operating efficiency, and balance sheet strength, which the committee identifies as a ‘red flag’ for systemic decay. This is compounded by a very low Value score of 1.25, suggesting the asset is a ‘value trap’ rather than a bargain. Furthermore, the macro environment is ‘risk_off’ (GPR percentile 89.82), which poses significant headwinds for the Financial Services sector. The News digest showed neutral sentiment (0.0), providing no positive catalysts to offset the deteriorating fundamentals.
Key Risks: Piotroski F-score of 0 indicating severe fundamental decay; Low Value score of 1.25 suggesting no margin of safety; Risk-off macro regime (GPR percentile 89.82) impacting the Financial Services sector; Lack of growth data or positive sentiment to offset structural weaknesses
CABR — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a complete failure of fundamental health metrics. The Piotroski F-score of 0 indicates a total collapse in profitability, leverage, liquidity, and operating efficiency. This is compounded by a Value score of 0.0, indicating no margin of safety or intrinsic value support. The macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82, which creates a hostile environment for assets lacking fundamental strength. The News digest showed a sentiment of 0.0, providing no positive catalyst to offset the deteriorating fundamentals. All committee members reached a consensus on a ‘Fail’ due to the lack of data, poor scores, and adverse macro conditions.
Key Risks: Piotroski F-score of 0 indicating severe financial instability; Value score of 0.0 indicating no margin of safety; Risk-off macro regime with high GPR percentile (89.82); Lack of any positive sentiment or qualitative moat
CACC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a critical lack of fundamental quality and a deteriorating macro outlook for the sector. The Piotroski F-score of 1 is a severe red flag, indicating significant weaknesses in profitability, liquidity, or operational efficiency. While the ‘Margin of Safety’ is listed as 73.11%, this is contradicted by the fact that the current price (545.96) is significantly higher than the Graham Number (395.2873), meaning no Graham-style discount exists. Furthermore, the News Digest showed ‘Bad’ sentiment regarding the sustainability of consumer car debt and a price target reduction by TD Cowen, signaling a deteriorating outlook for the credit cycle. The ‘risk_off’ macro regime (GPR_pct of 89.82) further compounds the risk for a credit-sensitive financial services firm.
Key Risks: Extremely low Piotroski F-score (1) indicating poor financial health; Current price (545.96) exceeds the Graham Number (395.2873), removing the margin of safety; Macro headwinds in the auto-lending sector due to high interest rates and debt costs; Risk_off macro regime (GPR_pct 89.82) penalizing high-leverage financial entities; Low Value Score (2.29) indicating poor market perception of intrinsic value
CALC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the Piotroski F-score of 0, which indicates a total failure across fundamental health metrics (profitability, leverage, liquidity, and operating efficiency). This is compounded by a very low Value score of 1.25, suggesting the asset is not viewed as a high-quality investment. The macro environment is currently ‘risk_off’ (GPR percentile of 89.82), which typically punishes companies with weak fundamentals. The News digest was present but provided no sentiment (0.0), offering no catalyst to offset the severe fundamental distress. All committee members reached a ‘Fail’ consensus based on the lack of margin of safety and the high probability of capital erosion.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Low Value score of 1.25 suggesting lack of intrinsic value or quality; Risk-off macro regime (GPR_pct 89.82) penalizing weak fundamentals; Lack of positive sentiment or growth catalysts
CAN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health as evidenced by a Piotroski F-score of 0. This score indicates a breakdown in profitability, liquidity, and operating efficiency. This is compounded by a very low Value score of 1.25, suggesting the asset is not undervalued relative to its risks. The News digest highlighted ‘Bad’ news regarding falling Bitcoin prices dragging down revenue, confirming the company’s lack of a moat and high sensitivity to external commodity cycles. Furthermore, the macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82, which is unfavorable for high-beta, speculative technology plays. The news digest also showed a price target reduction by B. Riley Securities, signaling cooling institutional optimism.
Key Risks: Piotroski F-score of 0 indicating severe fundamental deterioration; High sensitivity to Bitcoin price volatility and lack of pricing power; Unfavorable ‘risk_off’ macro environment (GPR_pct 89.82); Low Value score of 1.25 suggesting poor margin of safety
CAST — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for CAST is overwhelmingly negative across all committee dimensions. The core of the failure is the combination of a Piotroski F-score of 0 and a Value score of 0.0, indicating a complete lack of fundamental strength and no margin of safety. While the News Digest showed a ‘Bad’ outcome regarding the Q4 EPS of $(0.37) (missing the estimate by $(0.08)), it did note a ‘Beat’ on sales ($360.023K vs $100.000K estimate). However, the inability to convert this top-line growth into profit, coupled with a ‘risk_off’ macro regime (GPR percentile 89.82) and negative news sentiment (-0.0714), makes the stock highly speculative and unsuitable for a conviction call. The bear case of structural instability and lack of valuation cushion is not rebutted by the growth or value arguments.
Key Risks: Piotroski F-score of 0 indicating severe financial instability; Value score of 0.0 providing no margin of safety; Risk-off macro environment (GPR percentile 89.82) unfavorable for speculative assets; Inability to convert top-line growth into bottom-line profitability
CBT — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for CBT is fundamentally undermined by a critical Piotroski F-score of 1, indicating severe deterioration in financial health and operating quality. This is compounded by a significant valuation gap where the current price of 75.47 sits at a substantial premium to the Graham Number of 49.9698, leaving a thin Margin of Safety of 12.28% that is insufficient for a cyclical Basic Materials stock. The News Digest provided a ‘Bad’ signal via the UBS price target reduction to $86, which, while still above current price, signals cooling institutional sentiment. Furthermore, the ‘risk_off’ macro regime (GPR percentile 89.82) makes the low Value Score of 2.92 and the poor fundamental metrics a high-risk profile that fails to meet the criteria for a ‘Pass’.
Key Risks: Critically low Piotroski F-score of 1 indicating fundamental decay; Significant premium over the Graham Number (75.47 vs 49.9698); Thin Margin of Safety (12.28%) in a volatile sector; Risk-off macro environment with high GPR percentile (89.82)
CCAP — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is a clear ‘value trap.’ While the Margin of Safety is high at 60.59%, it is invalidated by the critically low Piotroski F-score of 1, which indicates severe fundamental decay and poor financial health. This is further compounded by a low Value score of 2.92 and a ‘risk_off’ macro regime (GPR percentile 89.82), which typically penalizes companies with weak fundamentals. The News digest confirmed a ‘Bad’ sentiment regarding analyst downgrades, and the overall consensus across all committees is that the discount is a reflection of structural weakness rather than an undervalued opportunity.
Key Risks: Piotroski F-score of 1 indicates extreme fundamental and balance sheet weakness; Risk-off macro environment (GPR percentile 89.82) penalizing low-quality assets; Low Value score (2.92) suggesting lack of competitive moat; Negative analyst sentiment and recent downgrades
CCBG — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the critically low Piotroski F-score of 1, which indicates severe fundamental decay in profitability, leverage, and liquidity. While the stock offers a 22.48% margin of safety relative to its Graham Number of 51.9488, the Bear and Value analysts correctly identify this as a ‘value trap’—where the discount is a reflection of structural weakness rather than an opportunity. This is compounded by a ‘risk_off’ macro regime (GPR percentile 89.82%) and a low Value Score of 3.93, suggesting the market is pricing in significant risks. The News Digest showed a neutral sentiment (0.0), providing no positive catalysts to offset the deteriorating fundamentals.
Key Risks: Piotroski F-score of 1 indicates extreme financial instability and potential for capital impairment.; Low Value Score of 3.93 suggests the market is pricing in significant structural risks.; Risk-off macro environment (GPR percentile 89.82%) creates a high-risk environment for a financially weak firm.; Potential ‘value trap’ where the 22.48% margin of safety is a result of fundamental decay.
CCG — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a ‘perfect storm’ of negative fundamental and macro indicators. The Piotroski F-score of 0 is a critical red flag, indicating that the company fails on all metrics of financial health (profitability, leverage, liquidity, and efficiency). This is compounded by an extremely low Value score of 1.25, indicating no margin of safety. While the News digest showed ‘Good’ sentiment regarding a ‘strategic investment’ and ‘growth phase,’ these qualitative headlines are insufficient to offset the quantitative evidence of financial decay. Furthermore, the macro environment is currently in a ‘risk_off’ regime (GPR percentile 89.82), which typically penalizes low-quality equities with poor fundamentals. The discrepancy between the positive news sentiment (0.225) and the catastrophic F-score suggests that any growth narrative is not supported by the underlying balance sheet.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Extremely low Value score (1.25) providing no margin of safety; Risk-off macro regime (GPR percentile 89.82) increasing volatility for low-quality assets; Potential disconnect between growth-oriented news and deteriorating fundamentals
CCTG — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ based on a consensus of critical failures across all committee analyses. The primary driver is the Piotroski F-score of 0, which indicates a total lack of positive fundamental indicators (profitability, liquidity, and efficiency). This is compounded by a very low Value score of 1.25, suggesting the asset is fundamentally broken or lacks a margin of safety. The macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82, which creates a hostile environment for speculative industrial stocks with such poor fundamentals. The news digest showed a sentiment of 0.0, indicating no positive catalysts to offset the severe fundamental risks.
Key Risks: Piotroski F-score of 0 indicating severe financial distress or deteriorating fundamentals; Extremely low Value score of 1.25 suggesting no margin of safety; Risk-off macro regime (GPR percentile 89.82) penalizing low-quality industrial equities; Potential for high volatility or delisting risk given the ‘penny stock’ price of 0.4005
CDLX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health. While the ‘Margin of Safety’ is high at 94.64%, this is deemed a ‘value trap’ because it is underpinned by a Piotroski F-score of 1, indicating extreme financial distress and deteriorating profitability. The ‘Value score’ of 1.67 confirms that the market does not view the asset as high-quality. Furthermore, the ‘risk_off’ macro regime (GPR percentile of 89.82) creates a hostile environment for distressed equities with such poor fundamentals. The News digest showed a neutral sentiment of 0.0, providing no catalyst to offset the structural risks.
Key Risks: Piotroski F-score of 1 indicates severe financial distress and deteriorating fundamentals.; Low Value score of 1.67 suggests the low price is a reflection of poor quality rather than an undervalued asset.; Risk-off macro environment (GPR percentile 89.82) penalizes companies with weak financial profiles.; Lack of growth catalysts or qualitative ‘moat’ to support a long-term hold.
CDRE — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a severe lack of margin of safety and deteriorating fundamental health. The current price of 26.15 is more than double the Graham Number of 12.1492, resulting in a negligible Margin of Safety of 1.65%. This is compounded by a critically low Piotroski F-score of 1, which indicates significant fundamental decay and poor operating efficiency. The News digest highlighted a ‘Bear Market’ for defense stocks, which are experiencing their ‘Longest Losing Streak on Record,’ creating significant sector-specific headwinds. The ‘risk_off’ macro regime (GPR percentile 89.82) further suggests an environment unfavorable for a stock with such weak internal fundamentals and a low Value score of 2.92.
Key Risks: Extreme valuation gap between current price (26.15) and Graham Number (12.1492); Critically low Piotroski F-score of 1 indicating deteriorating financial health; Negligible Margin of Safety of 1.65%; Sector-specific headwinds in the Industrials/Defense space as noted in the News digest
CDTG — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health as evidenced by a Piotroski F-score of 0, which indicates a collapse across profitability, leverage, and liquidity metrics. This is compounded by a very low Value score of 1.25, suggesting the asset is a ‘value trap’ rather than an undervalued opportunity. The macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82, which creates significant headwinds for an industrial stock with such poor fundamentals. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the structural risks. The lack of a Margin of Safety (0%) and the consensus across all committee members (Value, Growth, Bear, and Macro) confirm that the risk profile is unacceptable.
Key Risks: Piotroski F-score of 0 indicating severe fundamental and operational decay; Risk-off macro regime with GPR percentile of 89.82; Low Value score of 1.25 suggesting a value trap; Lack of any measurable growth metrics or competitive moat
CDZIP — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ based on a unanimous consensus across all committee members. The primary driver is the extreme failure of quantitative guardrails: a Piotroski F-score of 0 indicates severe deterioration in profitability, liquidity, and solvency. This is compounded by a Value score of 0.0 and a 0% Margin of Safety noted in the prior review, suggesting no floor for the current price of 20.85. Furthermore, the macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which is highly unfavorable for a cyclical industrial stock. The news digest showed a neutral sentiment of 0.0, providing no catalyst to offset the fundamental and macro headwinds.
Key Risks: Piotroski F-score of 0 indicating severe financial health deterioration; Value score of 0.0 indicating no margin of safety; Risk-off macro regime with high GPR percentile (89.82) impacting cyclical industrials; Lack of fundamental data regarding revenue growth or moat
CFFN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ primarily due to the critically low Piotroski F-score of 1, which indicates severe fundamental weaknesses in profitability, liquidity, or operating efficiency. While the stock trades below its Graham Number of 11.011 (providing a 23.87% margin of safety), the Bear and Value analysts correctly identify this as a potential ‘value trap’ given the low Value score of 2.86. The macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82, which poses significant headwinds for a Financial Services firm with deteriorating fundamentals. The News digest showed neutral sentiment (0.0), providing no positive catalysts to offset the fundamental risks.
Key Risks: Extremely low Piotroski F-score of 1 indicating severe fundamental instability; Low Value score of 2.86 suggesting market perception of high risk; Risk-off macro regime with GPR percentile of 89.82; Potential value trap where the 23.87% margin of safety is offset by deteriorating business health
ACAA — SELL
Verdict: Fail | Conviction: 0.92
Rationale: All four committee members (Value, Growth, Bear, Macro) independently concluded ‘Fail’ with high conviction. ACAA is a 2025-vintage SPAC with no operating business, zero revenue, zero margins, a current ratio of 0.021, negative price-to-book of -23.52, Piotroski F-score of 0, and 0.0% insider ownership. The macro regime is decisively risk_off (GPR percentile 89.82), which historically penalizes speculative pre-combination vehicles. No fundamental, valuation, growth, or flow catalyst supports the $10.02 price. The prior review (2026-09-24) also returned Fail with 0.9 conviction. No news digest was provided in the evidence bundle.
Key Risks: Negative equity (P/B -23.52) implies liabilities exceed assets; trust value may be below $10/share redemption floor; Current ratio 0.021 indicates inability to meet near-term obligations without a deal or financing; Zero insider ownership creates acute agency risk — sponsors incentivized to close any deal for promote; Risk_off macro regime (GPR 89.8) reduces appetite for speculative SPACs and increases redemption risk; No disclosed target, timeline, or sector focus — investment is pure binary speculation on unknown combination
AFCG — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected primarily due to a critical failure in fundamental health metrics. The Piotroski F-score of 0 indicates a complete breakdown in profitability, leverage, liquidity, and operating efficiency. While the current price of 3.1 is below the Graham Number of 5.9402, the extremely low Value score of 1.88 and the Bear analyst’s assessment suggest this is a ‘value trap’ where the discount reflects structural decay rather than an opportunity. This is further compounded by a ‘risk_off’ macro environment (GPR percentile of 89.82), which typically penalizes low-quality assets. The News digest showed neutral sentiment (0.0), providing no positive catalyst to offset the fundamental risks.
Key Risks: Piotroski F-score of 0 indicating severe financial instability; Low Value score of 1.88 suggesting poor quality and high risk; Risk-off macro environment (GPR > 80%) penalizing distressed assets; Lack of growth data and institutional support
AMAT — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected primarily due to a severe lack of margin of safety and deteriorating fundamental health. The Graham Number of 91.7643 compared to the current price of 464.24 results in a Margin of Safety of -596.43%, indicating the stock is trading at a massive premium to its intrinsic value. This is compounded by a Piotroski F-score of 1, the lowest possible score, signaling significant weaknesses in profitability and financial health. Furthermore, the macro environment is currently ‘risk_off’ (GPR percentile 89.82), which typically creates headwinds for high-valuation technology stocks. The News digest showed a slightly positive sentiment (0.0778), but this was insufficient to offset the extreme valuation gap and poor fundamental indicators.
Key Risks: Extreme overvaluation (Margin of Safety of -596.43%); Poor financial health (Piotroski F-score of 1); Macroeconomic ‘risk_off’ regime (GPR_pct 89.82) favoring defensive assets over high-premium tech; Potential for mean reversion in the semiconductor equipment space
AMTM — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected primarily due to the critically low Piotroski F-score of 1, which indicates severe deterioration in profitability, liquidity, or operational efficiency. While a Margin of Safety of 45.64% exists relative to the Graham Number (18.9441), the ‘risk-off’ macro regime (GPR percentile 89.82) significantly increases the probability of a ‘value trap’ for a cyclical industrial stock with such weak fundamental health. The news digest confirmed a downgrade to ‘Neutral’ and a lowered price target by BNP Paribas, signaling cooling institutional sentiment. The combination of a failing fundamental score, a risk-off environment, and a lack of clear growth catalysts outweighs the nominal margin of safety.
Key Risks: Piotroski F-score of 1 indicates severe fundamental decay; Risk-off macro regime (GPR percentile 89.82) penalizes weak industrial fundamentals; Potential ‘value trap’ where low price reflects deteriorating fundamentals rather than opportunity; Recent analyst downgrade to ‘Neutral’ and lower price target
ANDG — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected primarily due to a critical failure in fundamental health as evidenced by a Piotroski F-score of 1 (the lowest possible score), which indicates severe deterioration in profitability, efficiency, or financial stability. While a Margin of Safety of 54.21% exists, the extremely low Value score of 1.67 suggests this is a ‘value trap’ where the discount is a reflection of fundamental decay rather than an undervalued asset. The News digest showed an ‘Ugly’ security incident; while the company claims no material impact, the presence of such a risk in a ‘risk_off’ macro environment (GPR_pct of 89.82) makes the risk-reward profile unfavorable for a Consumer Cyclical stock. The bear case regarding the F-score of 1 remains unrefuted by the evidence.
Key Risks: Piotroski F-score of 1 indicates severe fundamental deterioration; Risk-off macro environment (GPR_pct 89.82) creates headwinds for Consumer Cyclical stocks; Potential for long-term brand erosion or regulatory scrutiny following the ‘Ugly’ security incident; Low Value score (1.67) suggests the market is pricing in significant risk
BBUC — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected primarily due to a critically low Piotroski F-score of 1, which indicates severe deterioration in fundamental health, profitability, or operating efficiency. While the Margin of Safety is high at 76.37%, the combination of a low Value Score (2.92) and the ‘risk_off’ macro regime (GPR percentile 89.82) suggests the discount is a ‘value trap’ rather than an opportunity. The News digest showed ‘Bad’ sentiment regarding a price target reduction to $29 by TD Cowen, confirming a lack of institutional confidence. The consensus across all committees is that the fundamental decay outweighs the margin of safety.
Key Risks: Piotroski F-score of 1 indicates extreme fundamental weakness; Risk-off macro environment (GPR percentile 89.82) creates headwinds for cyclical industrials; Low Value Score (2.92) suggests the asset is perceived as low-quality; Negative news sentiment and lowered price target from TD Cowen
BCML — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected primarily due to severe fundamental red flags and a lack of valuation support. The Piotroski F-score of 1 indicates a deteriorating financial position and poor operational health. This is compounded by a very low Value score of 1.29, suggesting the company is not a high-quality investment. While a Margin of Safety of 31.15% is reported, it is effectively neutralized by the fact that the current price (30.7) exceeds the Graham Number (28.909), meaning the stock is not trading at a discount to its primary valuation floor. Furthermore, the macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which is unfavorable for a company with such weak fundamentals. The News digest showed a sentiment of 0.0, providing no positive catalysts to offset the risk profile.
Key Risks: Piotroski F-score of 1 indicates severe financial distress and poor profitability.; Current price (30.7) exceeds the Graham Number (28.909), eliminating the value floor.; Low Value score of 1.29 suggests poor investment quality.; Hostile ‘risk_off’ macro environment (GPR percentile 89.82) penalizes weak fundamentals.
BOC — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment case for BOC is fundamentally undermined by a critically low Piotroski F-score of 1, indicating severe weakness in profitability and operational efficiency. This is compounded by a very low Value Score of 1.67, suggesting the stock lacks a margin of safety. The News Digest, while containing positive sentiment regarding a $30M buyback, also revealed a significant risk: the question of whether cash can cover the buyback before an ‘Insurance Sale,’ suggesting potential liquidity issues. These internal weaknesses are exacerbated by a ‘risk_off’ macro environment (GPR percentile 89.82), which typically penalizes companies with weak fundamentals in the Industrials sector. All committee members agreed on a ‘Fail’ verdict based on these factors.
Key Risks: Critically low Piotroski F-score (1) indicating poor financial health; Low Value Score (1.67) and 0% Margin of Safety; Potential liquidity crunch regarding the ‘Insurance Sale’ and buyback funding; Unfavorable ‘risk_off’ macro environment (GPR 89.82)
BRVE — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment decision is a ‘Fail’ based on a critical lack of fundamental health and a hostile macro environment. The Piotroski F-score of 0 indicates a complete failure across profitability, leverage, liquidity, and operating efficiency metrics. This is compounded by a Value score of 0.0 and a MoS of 0%, suggesting no margin of safety. Furthermore, the macro environment is currently in a ‘risk_off’ regime with a high GPR percentile of 89.82, which historically penalizes assets with poor fundamentals. The news sentiment is neutral (0.0), providing no catalyst to offset the structural weaknesses. The News digest was present but showed a neutral sentiment (0.0) from the headline_lexicon, which did not provide any bullish signal to override the poor fundamental scores.
Key Risks: Piotroski F-score of 0 indicating severe fundamental weakness; Value score of 0.0 and 0% Margin of Safety; Risk-off macro regime with high GPR percentile (89.82); Lack of positive sentiment or momentum
AARD — SELL
Verdict: Fail | Conviction: 0.88
Rationale: All four committee analyses converge on a Fail verdict. The company is a pre-revenue clinical-stage biotech with $0 revenue through 2025, negative free cash flow of -$54.27M (period ending Dec 2025), and cash of $47.05M (Dec 2025) implying <12 months runway. Its sole lead asset ARD-101 is under FDA clinical hold for unexpected cardiac signals, which caused a 32.1% share price drop in May 2026. Securities-fraud litigation related to the Feb 2025 IPO adds legal overhang. Fundamental scores are worst-in-class: Piotroski F-score 0, Value score 1.25. Macro regime is risk_off with GPR percentile 89.8, hostile to speculative biotech. The ‘cash-backed option’ narrative is undermined by the cash burn rate and the unexplained discrepancy between the cited $91M cash position and the reported $47.05M. The news digest (4 articles, headline lexicon sentiment 0.0) showed neutral sentiment and did not alter the negative assessment. Prior review (2026-09-24) also returned Fail with conviction 0.7. No rebutting evidence exists.
Key Risks: FDA clinical hold on sole asset ARD-101 due to cardiac safety signals; Zero revenue for 3+ years with -$54.27M FCF and <12 months cash runway; Securities-fraud litigation post-IPO; Risk-off macro regime (GPR 89.8 percentile) pressuring speculative biotech; Worst-in-class Piotroski F-score (0) and Value score (1.25); Unexplained cash position discrepancy ($47.05M reported vs $91M cited); Low insider ownership (15.8%) for pre-revenue biotech; Single binary catalyst (July 30, 2026 regulatory decision) with no pipeline diversification
ABNB — SELL
Verdict: Fail | Conviction: 0.85
Rationale: All four committee analyses converge on a Fail verdict. The quantitative evidence from the bundle is internally consistent and decisively negative: the stock trades at $165.58 versus a Graham Number of $36.13 (4.6×), implying a margin of safety of -25.93%; the Piotroski F-score is 1/9 and the composite value score is 1.67/10, indicating severely impaired fundamental quality. The macro regime is risk_off with GPR percentile 89.82 (top decile), which historically suppresses discretionary travel demand — a direct headwind for this Consumer Cyclical name. The prior review (2026-09-24) already flagged a Grey verdict with MoS -14%; the margin of safety has since deteriorated further to -25.93%. The news digest (9 articles, headline-lexicon sentiment -0.0222) showed marginally negative sentiment with one explicitly ‘Bad’ headline, but the flow is thin and offers no catalytic offset. Critical data gaps (no revenue, earnings, cash-flow, balance-sheet, insider, or litigation data) prevent any forensic rebuttal of the bear case. With every analytical lens (value, growth, bear, macro) aligned negatively and no offsetting evidence, the conviction for a Fail is high.
Key Risks: Extreme valuation dislocation: price 4.6× Graham Number, MoS -25.93%; Severely weak fundamentals: Piotroski F-score 1/9, Value score 1.67/10; Risk-off macro regime (GPR 89.82 percentile) pressuring discretionary travel demand; Consumer Cyclical sector exposure with no defensive characteristics; Critical data gaps preventing full financial-health or accounting-quality assessment; Worsening internal assessment: prior MoS -14% now -25.93%
ACR — SELL
Verdict: Fail | Conviction: 0.85
Rationale: All four committee members (Value, Growth, Bear, Macro) independently conclude Fail. The evidence shows a deeply negative margin of safety of -180.61% (prior -229%), a Piotroski F-score of 1/9, a value score of 1.67/10, and a macro regime of risk_off with GPR percentile 89.82 and yield curve 0.42 — all signaling severe overvaluation, deteriorating fundamentals, and a hostile environment for commercial real estate. The only positive news is a $5M buyback plan (sentiment +0.075), which analysts unanimously deem trivial relative to market cap and insufficient to offset the quantitative deterioration. No analyst offers a rebuttal to the bear case; the prior Grey verdict (conviction 0.4) has hardened to Fail as metrics worsened or failed to improve.
Key Risks: Margin of safety -180.61% indicates extreme overvaluation; Piotroski F-score 1/9 signals critical fundamental weakness; Value score 1.67/10 places stock in bottom percentile; Macro risk_off regime with GPR 89.82nd percentile and flat yield curve 0.42 pressures REIT valuations; No revenue growth, guidance, insider accumulation, or balance-sheet data to support a turnaround; Buyback of $5M is negligible and does not alter thesis
ADXN — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The evidence bundle contains no fundamental financial data (no revenue, EBITDA, cash flow, or balance sheet metrics). The Piotroski F-score is 0 (worst possible), the value score is 1.25/10 (deeply negative), and the prior review assigned a Grey verdict with 0% margin of safety and 0.0 conviction. The news digest of 8 articles shows neutral sentiment (0.0), providing no positive catalyst. The macro regime is risk-off with GPR percentile 89.8, adding external headwinds. The bear case (Piotroski 0, value score 1.25, zero MoS) is unrebutted by any fundamental improvement evidence. Therefore, the investment case fails.
Key Risks: Piotroski F-score of 0 indicates no positive fundamental signals; Value score of 1.25/10 signals extreme overvaluation or impairment; Prior margin of safety 0% with no evidence of improvement; Risk-off macro regime with high geopolitical risk (GPR 89.8); Absence of revenue, cash, pipeline, or catalyst data; Neutral news sentiment (0.0) across 8 articles offers no positive catalyst
AGL — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to a critical failure in fundamental health metrics. The Piotroski F-score of 0 is a definitive red flag indicating that the company failed every metric of the score, suggesting deteriorating profitability and weak cash flow. This is compounded by a Value score of 0.0 and a ‘risk_off’ macro environment (GPR percentile 89.82), which penalizes speculative plays. While the News digest showed a ‘Turnaround Story’ and a Bernstein upgrade, these qualitative sentiments are not supported by the underlying quantitative data, which suggests a ‘hype’ gap where analyst sentiment is decoupled from financial reality.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Value score of 0.0 indicating no measurable margin of safety; Risk-off macro environment (GPR percentile 89.82) favoring defensive assets over speculative turnarounds; Potential disconnect between positive news sentiment and poor fundamental metrics
AIZ — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to a critical failure in fundamental health and valuation alignment. The Piotroski F-score of 1 is a severe red flag, indicating extreme weakness in profitability, leverage, and operational efficiency. Furthermore, while a ‘Margin of Safety’ of 63.85% is cited, the current price of 270.99 exceeds the Graham Number of 240.9161, suggesting the stock is not trading at a discount to its tangible asset value. The ‘risk_off’ macro regime (GPR_pct of 89.82) and a low Value Score of 3.72 indicate a lack of market confidence and a high-risk environment that does not support a conviction for a value play. The News Digest showed a ‘Good’ headline regarding potential margin growth in Protection Services, but this was insufficient to offset the fundamental decay signaled by the F-score.
Key Risks: Piotroski F-score of 1 indicates severe financial distress or deteriorating fundamentals; Current price (270.99) exceeds the Graham Number (240.9161), nullifying the value thesis; Risk-off macro environment with high GPR percentile (89.82); Low Value Score (3.72) indicating lack of market confidence
ATOM — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to a critical failure in fundamental health and a hostile macro environment. The Piotroski F-score of 0 indicates a total failure across profitability, leverage, liquidity, and operating efficiency metrics. This is compounded by a Value score of 0.0, indicating no margin of safety. Furthermore, the macro environment is strictly ‘risk_off’ with a GPR percentile of 89.82, which historically penalizes technology assets lacking fundamental support. The news digest showed neutral sentiment (0.0), providing no positive catalysts to offset the deteriorating fundamentals and unfavorable macro backdrop.
Key Risks: Piotroski F-score of 0 indicating severe financial instability; Risk-off macro regime with high GPR percentile (89.82%); Lack of margin of safety (Value score 0.0); Absence of positive news catalysts or sentiment
ATRA — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment decision is a Fail based on a ‘perfect storm’ of negative indicators. The most critical factor is the Piotroski F-score of 0, which indicates a complete failure across profitability, leverage, liquidity, and operating efficiency. This is compounded by a Value score of 0.0, suggesting no intrinsic value premium. Furthermore, the macro environment is currently in a ‘risk_off’ regime (GPR percentile of 89.82), which typically penalizes companies with weak fundamentals. The News Digest showed a neutral sentiment of 0.0, providing no positive catalyst to offset the fundamental and macro risks.
Key Risks: Piotroski F-score of 0 indicating severe fundamental health deterioration; Risk-off macro regime with high GPR percentile (89.82); Lack of any valuation premium (Value score 0.0); Absence of positive news sentiment or catalysts
AVO — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment fails primarily due to a severe lack of margin of safety and poor fundamental health. The current price of 11.81 is significantly higher than the Graham Number of 2.4253, indicating a massive valuation premium. This is compounded by a Piotroski F-score of 1 (the lowest possible score), which signals significant fundamental weaknesses in profitability or financial stability. While the ‘Consumer Defensive’ sector and the ‘risk_off’ macro environment (GPR percentile 89.82) might typically favor the stock’s sector, the extreme valuation gap and the low Value score of 1.04 make it an unsuitable investment in the current environment. The News digest showed a ‘Good’ headline regarding the Peru business, but the sentiment score of 0.0167 was nearly neutral, providing no catalyst to justify the premium.
Key Risks: Extreme over-valuation (Price 11.81 vs. Graham Number 2.4253); Critical fundamental weakness (Piotroski F-score of 1); Low Value score (1.04); Risk-off macro environment penalizing high-premium assets
AXSM — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment fails primarily due to a complete lack of fundamental support and a high-risk macro environment. The Piotroski F-score of 0 and a Value score of 0.0 indicate that the company lacks profitability, liquidity, and any measurable margin of safety. While the News Digest showed positive analyst sentiment (RBC Capital ‘Outperform’ and Baird ‘growth potential’), these are qualitative projections that do not offset the quantitative ‘red flags’ identified by the Bear and Value committees. Specifically, the ‘risk_off’ macro regime (GPR percentile of 89.82) creates a high-risk environment where speculative assets with no fundamental floor (Piotroski 0) are highly susceptible to significant downside. The gap between the current price of 156.32 and the $295 target is based on speculative ‘hope’ rather than accounting strength.
Key Risks: Piotroski F-score of 0 indicating extreme fundamental weakness; Value score of 0.0 indicating no margin of safety; Risk-off macro regime (GPR percentile 89.82) penalizing speculative healthcare assets; High-beta profile with no underlying profitability to buffer against clinical or market volatility
BAH — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment decision is driven by a critical, unrebutted bear case regarding the company’s fundamental health. The Piotroski F-score of 1 is a severe red flag indicating deteriorating financial metrics and poor profitability trends. Furthermore, there is a significant valuation gap: the current price of 72.31 is nearly double the Graham Number of 37.8153, suggesting the stock is trading at a substantial premium to its intrinsic floor. While the News Digest showed positive sentiment regarding a ‘Post Quantum Cybersecurity Upgrade Cycle’ and an analyst upgrade to $85, these are momentum-based indicators that do not offset the systemic risk identified by the low Value score (3.54) and the ‘risk_off’ macro regime (GPR_pct 89.82). The mismatch between the ‘growth’ narrative and the ‘deteriorating’ fundamental data makes the stock a high-risk valuation play.
Key Risks: Piotroski F-score of 1 indicates severe underlying financial weakness; Significant premium over Graham Number (72.31 vs 37.8153); Risk-off macro environment (GPR_pct 89.82) may penalize high-multiple assets; Low Value score (3.54) indicates lack of fundamental safety
BCAX — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to a critical failure in fundamental health metrics. The Piotroski F-score of 0 indicates a total lack of positive financial characteristics (profitability, leverage, liquidity, and operating efficiency), suggesting a company in significant distress. This is compounded by a Value score of 0.0, meaning no margin of safety can be established. While the News digest showed a neutral sentiment of 0.0 (no clear signal), the macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which typically favors high-quality assets. Given the lack of any positive metrics and the presence of a critical bear case regarding the F-score, the ticker fails to meet the requirements for a conviction call.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Value score of 0.0 providing no margin of safety; Risk-off macro regime (GPR percentile 89.82) potentially accelerating capital flight from weak assets
BCRX — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment decision is driven by the severe deterioration of fundamental quality metrics which outweigh the high margin of safety. Specifically, the Piotroski F-score of 1 indicates extreme financial weakness and poor operational efficiency. This, combined with a very low Value score of 1.67, suggests the company lacks a sustainable competitive moat or high-quality business fundamentals. While the News digest showed some positive headlines regarding a Scientific Advisory Board and a ‘Newest Approval’, these qualitative improvements do not offset the quantitative failure of the F-score. Furthermore, the ‘risk_off’ macro environment (GPR percentile of 89.82) creates a high-risk environment for speculative biotech assets, increasing the probability of a ‘value trap’ where the 62.96% margin of safety is a reflection of fundamental decay rather than an undervalued opportunity.
Key Risks: Piotroski F-score of 1 indicates extreme financial and operational deterioration; Low Value score (1.67) suggests lack of fundamental quality or moat; Risk-off macro environment (GPR 89.82) penalizes speculative biotech assets; High probability of a ‘value trap’ despite the 62.96% margin of safety
BG — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment decision is a ‘Fail’ primarily due to the critically low Piotroski F-score of 1, which indicates severe and systemic weaknesses in the company’s fundamental health (profitability, liquidity, and operating efficiency). This is corroborated by both the Value and Growth analysts. Furthermore, the stock fails the ‘Margin of Safety’ test as the current price of 107.56 exceeds the Graham Number of 96.8483. While the News Digest showed some ‘Good’ sentiment regarding Q2 earnings outperformance, this is deemed a transitory headline beat that does not offset the structural risks identified by the F-score and the low Value score of 1.24. The ‘risk_off’ macro environment (GPR percentile 89.82) further penalizes the investment as the stock lacks a sufficient valuation cushion to withstand macro volatility.
Key Risks: Piotroski F-score of 1 indicates severe fundamental deterioration; Lack of margin of safety (Price 107.56 > Graham Number 96.8483); Low Value score of 1.24 suggesting poor valuation relative to fundamentals; Risk-off macro environment (GPR percentile 89.82) increasing volatility risk
BKV — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to the critically low Piotroski F-score of 1, which serves as a ‘smoking gun’ for deteriorating fundamentals, poor profitability, and declining operational efficiency. While the stock trades below its Graham Number of 36.3383 (current price 24.44), the combination of a low Value score (4.17) and a ‘risk_off’ macro regime (GPR percentile 89.82) suggests the discount is a ‘value trap’ rather than a margin of safety. The News digest showed a 7.4% price soar, but the underlying sentiment score of 0.0571 remains nearly neutral, failing to provide a compelling narrative to offset the severe fundamental risks identified by the Value and Bear committees.
Key Risks: Piotroski F-score of 1 indicates severe fundamental decay; Risk-off macro environment with high GPR percentile (89.82); Potential value trap where low price reflects deteriorating fundamentals rather than mispricing; High volatility in the cyclical Energy sector during periods of geopolitical stress
BLKB — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to a critical failure in fundamental health and a massive valuation disconnect. The Piotroski F-score of 1 is the lowest possible score, indicating severe weaknesses in profitability and financial stability. Furthermore, the current price of 48.06 is significantly higher than the Graham Number of 10.375, suggesting the stock is trading at a massive premium over its intrinsic value components. While the News Digest showed a ‘Good’ sentiment regarding a Baird price target of $58, this analyst opinion is outweighed by the forensic data showing a ‘risk_off’ macro regime (GPR_pct of 89.82) and a low Value score of 2.92. The ‘risk_off’ environment specifically penalizes high-multiple stocks with poor fundamental scores.
Key Risks: Critically low Piotroski F-score of 1 indicating poor financial health; Significant valuation gap between current price (48.06) and Graham Number (10.375); Risk-off macro environment (GPR_pct 89.82) favoring defensive positions over high-beta tech; Low Value score of 2.92 indicating lack of quantitative value
BLTE — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is a ‘Fail’ primarily due to the critical failure of fundamental health indicators. The Piotroski F-score of 0 indicates a complete breakdown in profitability, liquidity, and operating efficiency. This is compounded by a Value score of 0.0, suggesting no margin of safety for the current price of 151.87. The macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which typically penalizes stocks lacking fundamental support. The News digest contained 2 articles but showed a neutral sentiment of 0.0, providing no positive catalyst to offset the severe fundamental red flags.
Key Risks: Piotroski F-score of 0 indicating severe financial health deterioration; Value score of 0.0 indicating no margin of safety; Risk-off macro regime with high GPR percentile (89.82%); Lack of any positive sentiment or growth data to support current valuation
BMA — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment case for BMA is undermined by a critical ‘value trap’ signal. While the Graham Number of 84.464 relative to the current price of 65.71 suggests a mathematical Margin of Safety of 99.99%, this is heavily contradicted by the Piotroski F-score of 1. A score of 1 indicates severe fundamental decay and deteriorating profitability, suggesting the low price is a reflection of operational rot rather than a mispricing. This is further compounded by a low Value score of 2.84 and a ‘risk_off’ macro regime (GPR percentile 89.82), which typically penalizes low-quality assets in the Financial Services sector. The News digest showed ‘Good’ headlines regarding low P/B stocks, but this generic sentiment does not outweigh the specific, high-severity risk of the F-score of 1. The Bear’s argument regarding the ‘value trap’ is not rebutted by any evidence in the bundle.
Key Risks: Piotroski F-score of 1 indicating severe fundamental decay and potential value trap; Risk-off macro environment (GPR percentile 89.82) penalizing weak financials; Low Value score of 2.84 suggesting market awareness of underlying risks
BR — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment fails primarily due to a severe divergence between the market narrative and the underlying fundamental metrics. While the News Digest highlights the stock as a ‘Quality Dividend Growth Pick,’ this is contradicted by a Piotroski F-score of 1, which indicates significant fundamental deterioration in profitability and operational efficiency. Furthermore, the stock is trading at a massive premium to its intrinsic value; the current price of 168.44 is more than double the Graham Number of 73.3626, resulting in a thin Margin of Safety of only 7.45%. The low Value score of 2.92 confirms the stock is not a value play. The ‘risk_off’ macro regime (GPR percentile of 89.82) further increases the risk of a correction for a stock with such weak fundamental health and a high valuation premium.
Key Risks: Piotroski F-score of 1 indicating severe fundamental deterioration; Significant valuation gap between current price (168.44) and Graham Number (73.3626); Narrow Margin of Safety (7.45%); Macroeconomic risk-off environment with high GPR percentile
BWLP — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment fails primarily due to the critically low Piotroski F-score of 1, which indicates severe fundamental weaknesses in profitability, leverage, and liquidity. While a 42.09% Margin of Safety exists relative to the Graham Number (28.9126), the Bear and Value analysts correctly identify this as a potential ‘value trap’ given the low Value Score of 4.59 and the deteriorating operational health signaled by the F-score. The ‘risk_off’ macro regime (GPR percentile 89.82%) and the ‘cyclical’ nature of the Energy sector further increase the risk profile. The News digest showed a neutral sentiment of 0.0, providing no catalyst to offset the fundamental deterioration. The consensus across the Value, Growth, and Bear committees is that the mathematical margin of safety is insufficient to overcome the fundamental red flags.
Key Risks: Critically low Piotroski F-score of 1 indicating deteriorating fundamentals; High sensitivity to macro volatility in a ‘risk_off’ regime; Potential ‘value trap’ where low price is driven by poor operational health; Lack of positive news sentiment or catalysts
BWXT — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment fails primarily due to a catastrophic valuation disconnect and poor financial health metrics. The current price of 138.86 is nearly 4x the Graham Number of 35.5664, resulting in a Margin of Safety of -407.9%. This extreme overvaluation is compounded by a Piotroski F-score of 1, which indicates severe underlying financial weakness or deteriorating profitability. While the News Digest showed positive sentiment regarding ‘stable and predictable cash flows’ and ‘uranium processing capabilities,’ these qualitative narratives are not supported by the quantitative data. In a ‘risk_off’ macro environment (GPR percentile 89.82), the stock’s price appears driven by speculative sentiment rather than fundamental value, making it a high-risk play that fails the primary test of a margin of safety.
Key Risks: Extreme overvaluation relative to Graham Number (Margin of Safety -407.9%); Critically low Piotroski F-score of 1 indicating poor financial health; High risk of correction in a ‘risk_off’ macro environment; Low Value score of 1.67
CFG — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to the critically low Piotroski F-score of 1. While the stock offers a mathematically significant Margin of Safety of 38.03% (Graham Number of 76.6917 vs. current price of 63.3), the F-score of 1 is a definitive indicator of deteriorating profitability, liquidity, or operating efficiency. This suggests the stock is a ‘value trap’ where the low price is a reflection of fundamental decay rather than a market oversight. The ‘risk_off’ macro regime (GPR percentile 89.82) further penalizes low-quality assets. The News Digest showed ‘Good’ sentiment regarding expected earnings growth, but this is insufficient to override the severe structural risks identified by the Bear and Value committees.
Key Risks: Piotroski F-score of 1 indicates severe fundamental deterioration; Potential ‘value trap’ where low price reflects poor quality; Risk-off macro environment (GPR percentile 89.82) favoring capital preservation; Low Value Score of 2.79 suggesting market recognition of poor fundamentals
ACLS — SELL
Verdict: Fail | Conviction: 0.75
Rationale: Three of four committee members (Value, Bear, Macro) converge on a Fail verdict supported by unrebutted quantitative red flags: Graham Number 48.1058 versus current price 124.88 implies a margin of safety of -433.45% (price ~2.6× above conservative benchmark); Piotroski F-score of 1/9 signals severe deterioration in profitability, leverage, and operating efficiency; Value score of 0.42/10 shows virtually no fundamental value support. The macro regime is risk_off with geopolitical risk at the 89.8th percentile, a hostile backdrop for cyclical semiconductor capital equipment. The Growth analyst assigns Grey solely due to data insufficiency (no revenue, R&D, or market-share data) but does not rebut the bear case. The prior review (2026-09-24) already flagged Grey with 0.4 conviction and MoS -406%; the situation has worsened. News digest (8 articles, headline_lexicon source) showed neutral sentiment (0.0), providing no positive catalyst to offset the macro and valuation headwinds. Absent any offsetting fundamental data in the bundle, the convergent negative signals warrant a Fail verdict with high conviction.
Key Risks: Extreme overvaluation vs. Graham Number (48.11 vs 124.88, MoS -433.45%); Piotroski F-score of 1/9 indicating fundamental decay; Value score 0.42/10 showing no value support; Risk-off macro regime with GPR 89.8 percentile hostile to semi-cap equipment; No income-statement, balance-sheet, or cash-flow data to verify earnings quality or balance-sheet health; Neutral news sentiment (0.0 across 8 articles) offers no catalyst; Prior review already flagged severe overvaluation (MoS -406%) with low conviction
ACON — SELL
Verdict: Fail | Conviction: 0.70
Rationale: The evidence bundle contains two severe quantitative red flags: Piotroski F-score of 0 (worst possible) and Value score of 1.25/10 (bottom decile). The prior review (2026-09-24) already assigned Grey with 0% margin of safety and conviction 0.40. No new fundamental data (income statement, balance sheet, cash flow, revenue, R&D, pipeline) has been provided to offset these signals. The macro regime is risk_off with GPR percentile 89.82, which historically pressures micro-cap, low-quality healthcare names. News digest shows only 2 articles with neutral sentiment (0.0) from a crude headline_lexicon source, offering no catalyst visibility. Two analysts (Value, Bear) recommend Fail; two (Growth, Macro) recommend Grey pending data. No analyst recommends Pass. The bear case — anchored on the unrebutted Piotroski 0 and Value 1.25 — meets the threshold for a Fail verdict.
Key Risks: Piotroski F-score 0 indicates deterioration across profitability, leverage, liquidity, and operating efficiency; Value score 1.25/10 suggests market prices the stock as deeply distressed or fundamentally impaired; Prior verdict Grey with 0% margin of safety and low conviction (0.40); Risk-off macro regime (GPR percentile 89.82) penalizes micro-cap healthcare equities; Sub-$3 share price (2.14) flags micro-cap/distressed equity with liquidity and dilution risk; News digest present but no content supplied — blind spot for litigation, regulatory, or operational shocks; Complete absence of fundamental financials (revenue, EBITDA, debt, cash, FCF) prevents intrinsic valuation